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ABSTRACT  
 
Analysis of Some Novel Uterine Extracellular Matrix Proteins and a  
Growth Factor.  (May 2007)  
Saeed Y. Al Ramadan, D.V.M., King Faisal University;  
M.S., King Faisal University 
Chair of Advisory Committee: Dr. Robert C. Burghardt  
 
 
This dissertation focused on two classes of molecules implicated in processes of 
implantation and placentation in sheep and pigs.  Study one examined the temporal/spatial 
distribution of several Small Integrin-Binding Ligand, N-Linked Glycoprotein (SIBLING) 
family members in cyclic and pregnant ovine uterus.  Studies two and three evaluated the 
relationships between progesterone (P4) and estrogen (E2) and their receptors (PGR and 
ESR1, respectively) on FGF7 mRNA expression within the endometrium and placenta of 
pigs.   
Study one showed that dentin sialophosphoprotein (DSPP) was first detected in 
luminal epithelium (LE) of Day 15 cyclic and pregnant sheep.  Stromal expression of DSPP 
was first detected on Day 20 of pregnancy in stratum compactum and remained prominent in 
stroma through Day 120. Stromal DSPP protein was positively influenced by the conceptus 
based upon analysis of a unilaterally pregnant ewe model system. Immunoreactive dentin 
matrix protein 1 (DMP1), matrix extracellular phospoglycoprotein (MEPE) were localized to 
 iv 
the stroma of cyclic and pregnant sheep, however, these proteins appeared to be 
constitutively expressed.  BSP was not detected in ovine endometrium. 
Study two determined the effects of E2, P4, P4+E2, P4+the PGR antagonist (ZK137, 
316), and P4+E2+ZK on FGF7 mRNA expression in uterine LE of ovariectomized pigs. 
Results indicate that P4 is permissive to FGF7 mRNA expression by down-regulating PGR 
in LE; P4 stimulates PGR-positive uterine stromal cells to release an as yet unidentified 
progestamedin that induces FGF7 mRNA expression by LE; E2 and P4 can induce FGF7 
mRNA in the absence of PGR rendered nonfunctional by ZK.  
Study three showed the expression of ESR1, PGR and FGF7 in the uterine and 
placental tissue of pregnant pigs from Day 20 through 85. Results reveal a positive 
correlation between stromal cell expression of PGR and FGF7 mRNA which suggests that P4 
is permissive to FGF7 mRNA expression by down-regulating PGR in LE. FGF7 mRNA in 
later pregnancy is maintained by the release of progestamedin from PGR-positive stromal 
cells. A novel finding was the presence of ESR1 in porcine placenta on Days 20 through Day 
85 of pregnancy suggesting that E2 may play important roles in the placental biology of the 
pig.  
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CHAPTER I1 
INTRODUCTION AND LITERATURE REVIEW 
 
 This dissertation is focused on the expression of several proteins which are thought to 
play a role in the uterus during early pregnancy. The following literature review first 
considers events occurring in the uterus of the two animal models, sheep and pig, used in 
these investigations including maternal recognition of pregnancy, implantation and 
placentation.  This is followed by an overview of members of two protein families 
investigated in this dissertation including the SIBLING family of extracellular matrix 
proteins and fibroblast growth factor 7, a member of the fibroblast growth factor family. 
 
Maternal Recognition of Pregnancy 
In domestic mammals, ovulation is spontaneous and the reproductive cycles are 
dependent on the uterus, because it is the source of the luteolytic factors that lead to the 
structural and functional regression of the corpus luteum (CL), which is the main source of 
the pregnancy hormone, progesterone (P4). During early diestrus, P4 from the newly formed 
CL stimulates accumulation of phospholipids in the uterine LE that can liberate arachidonic 
acid for synthesis and secretion of the luteolytic factor, prostaglandin F2 (PGF) (McCracken 
et al. 1999). Oxytocin, secreted from the posterior pituitary and/or CL, then induces release 
of PGF pulses from the LE which results in luteolysis and declining P4 levels (Wathes & 
Lamming 1995). However, in case of pregnancy and before any intercellular contacts are 
                                                 
 This dissertation follows the style of Reproduction. 
 2 
established, signals from the embryo act on the endometrium to prevent uterine release of 
luteolytic PGF to sustain the function of the CL during the early stages of pregnancy, a 
process referred to as ‘maternal recognition of pregnancy’ (Spencer & Bazer 2004).  
 
Maternal recognition of pregnancy in sheep 
During diestrus of sheep, P4 levels increase and act via progesterone receptor (PGR) 
to block the expression of E2 receptor  (ESR1) and oxytocin receptor (OTR) in the LE and 
superficial ductal glandular epithelium (sGE). Therefore, ESR1 and OTR expression are not 
detected in the LE between Days 5 and 11 of the cycle, i.e., during most of diestrus 
(McCracken et al. 1984). Moreover, continuous exposure of the uterus to P4 for 8 to 10 days 
down-regulates expression of PGR in the LE and sGE after Days 11 to 12, allowing for rapid 
increases in expression of ESR1 on Day 13 followed by OTR on Day 14 in LE and sGE 
(Spencer et al. 1995 a,b). Oxytocin, secreted at Day 9 of the estrous cycle and pregnancy 
from the posterior pituitary and/or CL, then induces release of luteolytic PGF pulses from the 
endometrium on Days 14 to 16 (Wathes & Lamming 1995, Gray et al. 2000). In sheep, 
however, the source of luteolytic PGF pulses is the LE and sGE (Gray et al. 2000), because 
they express the oxytocin receptors (OTR) (Wathes & Lamming 1995) and are the only 
uterine cell types that express cyclooxygenase 2 (COX-2), a rate limiting enzyme in the 
synthesis of prostaglandins (Kim et al. 2003). These luteolytic pulses of PGF make the CL 
undergo regression, allowing the ewe to return to estrus and complete the 17-day estrous 
cycle. In the sheep interferon tau (IFN), which is secreted by trophectoderm of the elongated 
conceptus between Days 10 to 25 with maximal production on Days 14 to 16, is the signal 
for the maternal recognition of pregnancy (Bazer 1992, Roberts et al. 1999). Further, IFN 
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appears to be the sole factor produced by the conceptus that prevents development of the 
endometrial luteolytic mechanism (Spencer & Bazer 2004). It is most likely that IFN acts in 
a paracrine fashion on endometrial LE and sGE to suppress transcription of ER which 
presumably inhibits OTR genes to abolish the development of the endometrial luteolytic 
mechanism (Spencer et al. 1995a, Spencer & Bazer 1996, Fleming et al. 2001, Spencer et al. 
2004a). However, the 5' promoter/enhancer region of the ovine OTR gene was cloned and 
the binding site for ESR1 was not found; rather proximal SP1 sites mediated ESR1 action 
(Fleming et al. 2006). Thus IFN may directly inhibit OTR gene transcription. 
 
Maternal recognition of pregnancy in pig 
 In the pig, establishment of pregnancy begins about 11-12 days after the start of 
estrus. The ability of pig conceptuses to synthesize and release estrogens during this period, 
as well as the ability of exogenous estrogens to induce pseudopregnancy when administered 
from Day 11-15 of the estrous cycle, provides evidence for an involvement of estradiol-17 
(E2) in the maternal recognition of pregnancy in the pig. It had also been reported (Geisert et 
al. 1982a, Bazer et al. 1986, Vallet & Christenson 1996) that E2 derived from the conceptus 
or from administration to cyclic gilts stimulates uterine secretion of calcium and total 
proteins on Day 11-12. The proposed role for estrogen in the maintenance of pregnancy in 
the pig is the prevention of luteolysis through reorientation of endometrial PGF release from 
an endocrine to an exocrine mechanism, i.e. redirection the PGF secretion from directly into 
the blood circulation to the uterine lumen (Perry et al. 1973, Bazer & Thatcher 1977, Geisert 
et al. 1982b).  It was also reported that estrogen is secreted by the pig conceptuses in a 
biphasic pattern with the initial surge of estrogen secretion occurring on Day 12 and the 
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second phase of a high level of estrogen secretion occurring on Days 15-20. Geisert et al. 
(1990) suggested that the second surge of estrogen secretion is necessary for prolonged CL 
maintenance. Another proposed mechanism of estrogen action is that it possibly acts directly 
or indirectly on the CL by a mechanism not involving the uterus (Ziecik 2002). This theory 
was based on the findings from intact cyclic gilts treated with anti-luteolytic doses of 
estrogen on Day 12 after estrus resulted in a delay in luteal regression and was accompanied 
by a three-fold increase in luteinizing hormone receptor concentration at the CL. Similar 
effects could be obtained from gilts hysterectomized on Days 6-9 after estrus and treated with 
estradiol benzoate on Day 12 (Garverick et al. 1982). These findings lead Ziecik (2002) to 
conclude that estrogen may increase the LH receptor levels without involving the uterus but 
through effects on circulating concentrations of the pituitary hormones. According to this 
theory, it is possible that LH can stimulate prostaglandin secretion from endometrium of pigs 
through increasing expression of some angiogenic growth factors, like vascular endothelial 
growth factor (VEGF). However, no further details were given for the mechanism of how 
these growth factors work to maintain the CL and hence, the pregnancy. Finally, based on the 
assumptions that E2 could change PGE2:PGF2 secretion ratio (Zhang & Davis 1991) and 
that PGE2 has a luteotrophic/anti-luteolytic effect (Akinlosotu et al. 1986; 1988), E2 may 
protect the CL from the luteolytic effects of PGF through increasing the PGE2:PGF2 ratio. 
 
Implantation 
During maternal recognition of pregnancy, the uterine environment is changed from a 
non-receptive to a receptive state. These changes require structural and functional modulation 
of the endometrium in order to support intimate contact of the balstocyst with the uterine 
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wall in a process referred to as implantation, which will culminate with the formation of 
placenta. This reproductive strategy ensures efficient nutrition and protection of the 
embryo(s) and thus promotes their survival. However, this process is evolutionarily recent 
and therefore the mechanism is highly diverse among taxonomic groups. In contrast, the 
processes between fertilization and the initiation of implantation are highly conserved. These 
processes include shedding of the zona pellucida, followed by orientation, apposition, 
attachment and firm adhesion of the blastocyst to the endometrium (Lee & DeMayo 2004, 
Spencer et al. 2004a). In fact, these processes require both that the uterus has undergone a 
specified sequence of differentiation controlled by ovarian steroids and that the blastocyst has 
reached a precise stage of activation and both the blastocyst and the uterus must operate in 
synchrony. They must express, at the same time, the precise molecular repertoire required for 
adhesive interaction between TR and LE (Kimber 2000). 
Regardless the types of the implantation and placentation, the adhesion process 
begins with a close interaction of embryonic trophoblast, the outermost extraembryonic cell 
layer, and endometrial LE cells which involves intimate interactions of apical surfaces of the 
LE of the uterus and trophoblast cells from the embryonic side.  This event is mediated 
through the binding of adhesion molecules secreted from the glandular epithelium (GE) 
and/or LE to receptors on the apical surface of the conceptus trophectoderm and LE (Bowen 
& Burghardt 2000). For the embryo to implant, it must first come in contact with the apical 
surface of the LE (apposition), after which it undergoes firmer attachment. Attachment may 
continue throughout pregnancy in the epitheliochorial placentation of pig or be a transient 
event, as in the mouse and human (Kimber 2000, Kimber and Spanswick 2000).  
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In primates and some subprimate species such as rodents, implantation is marked by a 
significant degradation of part of the maternal endometrial tissues by the invasive trophoblast 
to bring the fetal membranes and blood vessels in close contact to the maternal blood 
circulation. However, for species with lesser invasive types of implantation, like the domestic 
animals, the alterations in the endometrial surface are minimal or involve molecular 
interactions at the apical surfaces of apposing uterine and conceptus epithelia. For example in 
the pig, the shift in the status from non-receptive to receptive is marked by a decrease in PGR 
and ESR1 in the LE, an increase in the expression of some extracellular matrix proteins 
and/or changes in the pattern of the integrin expression (Geisert et al. 1993, 1994). In 
contrast, stromal, myometrial and some vascular cells maintain these steroid receptors, which 
are likely mediate the action of these steroid hormones through the secretion of specific 
factors (estromedins and progestamedins) that act on the LE (Spencer & Bazer 2002, Spencer 
et al. 2004a). However, the paradigm of loss of PGR in uterine epithelia immediately before 
implantation is common across mammals (Carson et al. 2000, Spencer et al. 2004a) and can 
be directly correlated with reduced expression of certain genes, such as the antiadhesive 
protein MUC1 or induction of others like secreted phosphoprotein 1 (SPP1, also known as 
osteopontin) (Johnson et al. 2001, 2003a).  
 
Implantation in sheep 
 Areas of contact between the trophectoderm and the uterine epithelium can be 
detected at Day 15 of pregnancy. On Day 16, uterine lavage to recover the conceptus causes 
superficial structural damage to the conceptus at this time. The interdigitation of the 
trophectoderm and endometrial LE occurs in both the caruncular and intercaruncular areas of 
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the endometrium. Adhesion of the trophectoderm to the endometrial LE progresses along the 
uterine horn and appears to be completed around day 22 (Bowen & Burghardt 2000, Spencer 
et al. 2004b). In the intercaruncular spaces, the trophoblast develops fingerlike villi or 
papillae, which penetrate into the mouths of the superficial ducts of the uterine glands at 
Days 15–18 then disappear at Day 20 (Guillomot et al. 1981, Wooding et al. 1982). These 
trophoblastic differentiations are hypothesized to anchor the peri-attachment conceptus and 
absorb the histotrophic secretions of the glands (Guillomot et al. 1981). Furthermore, the 
trophoblast papillae are hypothesized to facilitate the formation of more robust adhesive 
interactions between the trophoblast and endometrial LE (Wooding et al. 1982, Spencer et al. 
2004b).   
At this stage of implantation, two morphologically and functionally distinct cell types 
have been recognized in the trophectoderm of the placenta of ruminant animals. These are 
the mononucleate trophoblast cells and the giant binucleate trophoblast cells (Igwebuike 
2006). The trophoblast giant binucleate cells (BNC) are thought to be differentiated from the 
mononuclear trophoblast by Day 16 (Hoffman & Wooding 1993).Giant BNCs typically 
exhibit the capacity for migration or invasion, although the degree of migratory activity 
varies among species while mononuclear trophoblast cells are able to adhere to the 
endometrial LE (Hoffman & Wooding 1993, Guillomot 1995). Interestingly, maximum 
expression of IFN could be observed at Day 14 and the level decreased by Day 16 of 
pregnancy. Moreover, the expression of IFN was arrested in the regions of trophoblast 
which have established cellular contacts with the uterine epithelium during the implantation 
process (Guillomot et al. 1990). At least two main functions for BNC have been reported: 1) 
to form a hybrid fetomaternal syncytium essential for successful implantation and subsequent 
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placentomal growth; 2) to synthesize and secrete protein and steroid hormones, such as 
placental lactogen and P4 that regulate maternal physiology (Wooding 1982, Hoffman & 
Wooding 1993, Spencer et al. 2004b). 
 
Implantation in pig 
Between Days 12 to 13 after fertilization the attachment process commences (Keys & 
King, 1990). However, implantation in this species remains superficial. However, the 
trophoblast and LE become closely apposed and the adhesion process appears to be 
facilitated by the modification of the glycocalices associated with epithelial and chorionic 
cells.  The apical surfaces of these cells are characterized by loss of microvilli on embryonic 
cells and reduction in the thickness of anti-adhesion molecules like MUC1 enhancing access 
for blastocyst attachment (Bowen et al. 1996). Interestingly, although the pig demonstrates 
true epitheliochorial placental development, the barrier to invasiveness is a property resident 
in the LE because, like blastocysts of other species, the pig blastocyst is inherently invasive 
and will invade and undergo syncytium formation when transplanted to an ectopic site 
(reviewed in Burghardt et al. 2002). It is noteworthy that both the conceptus and uterine LE 
express a number of common integrin subunits including 1,  3,  4,  5,  v, ß1, ß3, and 
ß5, and of these, the  4,  5,  v, ß1, ß3 andß5 subunits are detected at sites of initial 
attachment between uterine LE and TR on Days 12–15 of pregnancy (Bowen et al. 1996). 
Once the union between the trophectoderm and LE cells is established, conceptus 
microvilli reform and begin to interdigitate with counterparts on uterine epithelial cells to 
consolidate association (Burghardt et al. 1997; King 1993). The blood vessels that develop 
from the blastocyst and those from the uterus do not traverse respective epithelia, so the 
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integrity of both the maternal and fetal tissues is not disrupted (Carson et al. 2000). It is 
noteworthy that estrogens produced by the conceptus stimulate increases in ultrastructural 
features associated with synthesis and secretory activity, accumulation of glycogen, variation 
in nuclear position, elaboration of a thick glycocalyx, and reduced cellular degeneration in 
LE (Keys & King 1992).  
 
Placentation 
Placentation is the growth and formation of the placenta (which consists of four 
layers, the chorion, amnion, yolk sac and allantoic sac) and the development of the uterine 
capacity to supply the nutrients and oxygen required by the fetus. Although the placentas of 
all eutherian species provide common functional purpose, there are species variations in the 
gross and microscopic levels. In ruminant ungulates, the placenta is classified as 
cotyledonary on the basis of its gross anatomical features and it exhibits discrete areas of 
attachment, the placentomes, which are formed by interaction of patches of the 
chorioallantois with the endometrium. The fetal portion of the placentome is the cotyledon, 
while the maternal contact sites are the caruncles. The richly vascularized chorioallantois is 
lined on its external surface by cells of the trophectodermal epithelium. These cells assume 
specialized functions and are referred to as trophoblast cells. In ruminants, chorionic 
binucleate cells migrate across the fetomaternal space and fuse with and become incorporated 
into the LE, forming hybrid of tri-and multinucleated syncytia (Wooding et al. 1993). On the 
other hand, pigs have diffuse, non-invasive placenta classified as being epitheliochorial 
where the uterine epithelium of the pig inhibits trophoblast cell migration so that fetal and 
maternal tissues remain separate and intact throughout gestation (King 1993).  
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In general, implantation and placentation are dependent on the establishment and 
maintenance of an adequate fetomaternal contact. Consequently, functional coordination of 
trophoblast, LE, stroma, immune cells, and vascular endothelial cells must occur during 
different stages of placental development. This type of coordination has been considered to 
be mediated by hormones, transcription factors, growth factors, cell adhesion molecules, and 
extracellular matrix proteins (Regnault et al. 2002, Wei et al. 2004). In the next section, 
focus will be directed toward SIBLING proteins, a group of related extracellular matrix 
proteins, and Fibroblast Growth Factor 7, a member of the large fibroblast growth factor 
family which were investigated in this dissertation research. 
 
The Small Integrin-Binding Ligand N-Linked Glycoprotein Family 
The small integrin-binding ligand N-linked glycoprotein (SIBLING) gene family 
includes five closely related members: bone sialoprotein (BSP), secreted phosphoprotein 1 
(SPP1), dentin matrix protein 1 (DMP1), matrix extracellular phosphoglycoprotein (MEPE), 
and dentin sialophosphoprotein (DSPP). A sixth protein, enamelin (ENAM) has been 
identified as a more distant member of the family (Fisher & Fedarko 2003).  
SIBLING proteins are found in the bone and dentin and are secreted into the 
extracellular matrices (ECM) during the formation and mineralization of these tissues (Fisher 
& Fedarko 2003; Qin et al. 2004). In the human genome SIBLING protein genes are 
clustered within a 375 kb region on human chromosome 4q21, in chromosome 14 of the rat, 
and chromosome 5 of the mouse (Huq et al. 2005). Moreover, it was reported that SIBLNG 
protein genes have similar exon structures.  For example, exon 1 is always noncoding, exon 2 
is the leader sequence and the first two amino acids of the mature protein, exons 3 and 5 
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usually contain the consensus sequence (SSEE) for casein kinase II (CKII) phosphorylation.  
Exon 4 is usually proline rich, and among the acidic proteins, is the only significantly 
positive-charged domain. However, the majority of each protein is encoded by the last one or 
two exons and contains the integrin-binding tripeptide Arg-Gly-Asp (RGD) (Fisher & 
Fedarko 2003; Huq et al. 2005).  
The dominant view of protein structure-function is that an amino acid sequence 
specifies a three-dimensional (3-D) structure that is a prerequisite for protein function. In 
contrast, many proteins display functions requiring intrinsic disorder. Moreover, proteins 
from eukaryotes apparently have more intrinsic disorder than those from prokaryotes with 
typically 30% of eukaryotic proteins having disordered regions of length  50 consecutive 
residues (Dunker et al. 2002). Of the SIBLING proteins, BSP and SPP1 have been reported 
to be completely unstructured and flexible in solution based on NMR spectroscopy studies 
(Fisher et al. 2001). Recently, it was also reported that dentin phosphoprotein (DPP), a 
domain encoded by the DSPP gene, is a uniformly flexible molecule (Cross et al. 2005). The 
lack of structure may be a useful property in molecular recognition because disordered 
regions enable high specificity coupled with low affinity.  For example, one protein can bind 
to differently shaped partners, different disordered sequences can fold to bind a common 
binding site, faster rates of association can be achieved by reducing dependence on 
orientation factors and by enlarging target sizes, and faster rates of dissociation may be 
achieved by unzippering mechanisms (Huq et al. 2005; Dunker et al. 2001, 2002). The 
properties displayed by disordered proteins explain the multifunctionality reported for the 
SIBLING proteins.  For example, SPP1 and BSP are able to rapidly associate with a number 
of different binding partners, e.g. integrin and factor H, as well as the mineral phase of bones 
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and teeth and these features may also be reflected in broad tissue distribution of SPP1 (Huq 
et al. 2005). 
Because of their primary association with cells that produce mineralized extracellular 
matrix, SIBLING proteins have been hypothesized to play roles in mineralization.  However, 
there is now accumulating evidence showing that members of this protein family can be 
synthesized and secreted in nonmineralized tissues.  DMP1 protein was localized in mouse 
brain, pancreas, and kidney by immunohistochemistry (Terasawa et al. 2004). Moreover, the 
expression of BSP, SPP1, DMP1, MEPE and DSPP were detected in the salivary gland of the 
mouse and the kidney of the monkey (Ogbureke & Fisher 2004, 2005). SPP1 expression 
could also be detected at the luminal surfaces of different organs and cell types including the 
gastrointestinal tract, gall bladder, pancreas, urinary and reproductive tracts, lung, breast, 
salivary glands, and sweat glands and by leukocytes, smooth muscle cells (Brown et al. 1992, 
Ashkar et al. 2000, Garlow et al. 2002). Additionally, there are extensive reports describing 
SIBLING protein expression in different cancer tissues (Hotte et al. 2002, Fisher et al. 2004, 
Rangaswami et al. 2006, Chaplet et al. 2003, 2006, Karadag et al. 2004). 
 
SIBLINGs in reproduction 
In the reproductive tract, SPP1 is hypothesized to be a critical component of 
pregnancy in different animal species and its role in reproduction of humans, rabbits, rodents, 
sheep, goats and pigs has been the focus of a number of studies during the past few years 
(Johnson et al. 1999a, 2000, 2001, 2003a, Garlow et al. 2002, Joyce et al. 2005, White et al. 
2005, 2006). The precise physiological role of SPP1  in pregnancy has not been elucidated 
fully, but there is growing evidence that SPP1 influences the uterine environment as: 1) a 
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component of histotroph required for adhesion and signal transduction at the uterine-
placental interface;  2) a gene product expressed by uterine stroma as it decidualizes in 
response to conceptus invasion; and 3) a product of resident placental and uterine immune 
cells that regulates their behavior and cytokine production (Johnson et al. 2003a). Early 
studies focused on the role of epithelial-derived SPP1 as a P4-induced secretory product of 
uterine glandular epithelium (GE) that binds receptors on the apical surface of uterine LE and 
conceptus trophectoderm to stabilize adhesion between uterus and conceptus for implantation 
(Garlow et al. 2002, Johnson et al. 2000, 2001). Later studies were focused on the expression 
of SPP1 in the stroma of sheep, which provided novel evidence that stromal SPP1 expression 
is linked to a decidualization-like differentiation response during pregnancy (Johnson et al. 
2003a). In this respect, SPP1 mRNA and protein have been detected in decidualized stroma 
of species that undergo invasive implantation, including mice, baboons, and humans and is 
considered to be a gene marker for decidualization (Burghardt et al. 2006, Carson et al. 2002, 
Briese et al. 2005).  
It is noteworthy that the endometrial stromal cells in pregnant ewes were reported to 
change following conceptus attachment, and exhibited morphological changes about the time 
when the expression of SPP1 mRNA and protein was observed in uterine stromal 
compartment. In contrast, neither morphological changes in uterine stroma nor induction of 
SPP1 mRNA and protein were detected during porcine pregnancy (Johnson et al. 2003b). 
Although both sheep and pigs have noninvasive implantation, there are subtle differences in 
the in type of placentation. Pig conceptuses undergo true epitheliochorial placentation in 
which LE remains morphologically intact throughout pregnancy and the conceptus 
trophectoderm simply attaches to the apical LE surface without contacting uterine stromal 
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cells.  In contrast, sheep have synepitheliochorial placentation where LE cell disintegration 
results in areas of epithelial erosion into which trophectoderm binucleate cells migrate and 
eventually fuse with remaining epithelial cells to form syncytia; however, invasion into the 
stroma does not occur.  Therefore, Johnson and coworkers (2003b) have suggested that the 
uterine stroma of sheep undergoes a program of differentiation that has features that are 
similar to decidualization in invasive implanting species.  Porcine stroma exhibits a type of 
differentiation that is more limited than that observed in sheep, rodents, or primates. Results 
suggest that uterine stromal decidualization and decidualization-like responses are common 
to species with different types of placentation, but the extent is variable and correlates with 
the depth of trophoblast invasion during implantation (Johnson et al. 2003b). 
 
SIBLINGs and MMPs 
Matrix metalloproteinases (MMPs) form a family of structurally and functionally 
related zinc-dependent proteolytic enzymes. They are synthesized as secreted or 
transmembrane proenzymes and processed to an active form by the removal of an amino-
terminal propeptide. Collectively, these MMPs are capable in vitro and in vivo of degrading 
many extracellular matrix protein components such as interstitial and basement membrane 
collagens, proteoglycans, fibronectin and laminin (Massova et al. 1998, Bode et al. 1999). To 
date, at least 26 members of the MMP family have been reported and all contain a propeptide 
and a catalytic domain. Due to their potential for tissue damage if inappropriately activated, 
the MMPs are tightly regulated at different levels.  These include: 1) the transcriptional level, 
depending on various cis-elements present in their gene promoter, and various factors (e.g. 
hormones, cytokines, and growth factors) able to induce gene expression; 2) at the secretion 
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level, depending on packaging in secretion granules; or 3) at protein level by either an 
activation of the zymogen form or by inhibition of the active form through tissue inhibitor of 
matrix metalloproteinase (TIMPs).  Further, regulation might depend on the stabilization of 
the MMPs by posttranslational modification such as glycosylation (Van den Steen et al. 
2001, Cohen et al. 2006). In addition, nitric oxide (NO) and peroxynitrite are involved in the 
cleavage of the MMPs proenzymes, leading to the formation of the enzymes with biological 
activity in different cell types (Zhang et al. 2004, Biondi et al. 2005). Regardless of the 
regulatory procedure, it is widely accepted that the inhibitory propeptide must be removed 
before the MMP can be enzymatically active.  After the removal of the propeptide, the MMP 
typically remains active until a TIMP binds and inactivates the protease.  
To date, several MMP members have been reported in association with implantation 
and placentation events including MMP1, MMP2, MMP3, MMP7 and MMP9, MMP14, 
MMP15, MMP26. However, MMP2 and MMP9 are the most studied in trophoblastic cell 
invasion (Isaka et al. 2003, Cohen et al. 2006). Interestingly, there is a report showing that 
three members of the SIBLING family can specifically bind and activate three different 
MMPs. Activation includes both making the proMMPs enzymatically active and the 
reactivation of the TIMP inhibited MMPs (Fedarko et al. 2004). Bone sialoprotein was 
shown to specifically bind proMMP-2 and active MMP-2, while SPP1 binds proMMP-3 and 
active MMP-3, and dentin matrix protein-1 binds proMMP-9 and active MMP-9. Subsequent 
studies confirmed these findings by colocalizing different MMPs to their partner SIBLING 
family members in different tissues (Ogbureke & Fisher 2004, 2005; Karadag et al. 2005). 
Collectively, these studies indicate that, even in the presence of TIMPs, MMPs may be 
enzymatically active in regions of locally high concentrations of specific SIBLINGs.  It is 
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noteworthy that these SIBLING proteins have been correlated with cancer progression and 
metastasis (Fisher et al. 2004); it is therefore interesting to consider that these proteins may 
be locally activating their corresponding proteases in implantation and trophoblastic cell 
invasion.  
 
SIBLINGs and factor H 
 Factor H is a multidomain, multifunctional plasma protein that was first isolated in 
1965, and is present in human plasma at a concentration of about 500 µg/mL. In the immune 
system, Factor H is a central discriminator of self and non-self structures by acting as a 
regulator of the early activation cascade of the complement system (Zipfel, 2001). The 
complement system found in the blood of mammals is composed of about 26 proteins that 
combine with antibodies or cell surfaces as part of host humoral surveillance and plays a role 
in inflammation, immune adherence and cell lysis. The complement system can be activated 
via two distinct pathways: the classical (antibody initiated) pathway and the alternate 
pathway. The classical and alternate pathways consist of a series of humoral protease 
activation cascades that result in cell lysis (Maarten et al. 1985). One of the complement 
components, C3, plays a central role in the complement system, and is common to both 
pathways. C3 along with other plasma glycoproteins engage in an activation cascade that 
results in lysis of foreign cells or in their opsonization as a prelude to phagocytosis. Cleavage 
of C3 by C3 convertases gives rise to two activated fragments, the anaphylatoxin C3a-a 
vasoactive peptide and C3b. Surface-bound C3b acts as a cofactor in the formation of C5 
convertase and thus can complete activation of the complement cascade (Maarten 1985, 
Liszewski et al. 1991). Basically, all cells are subject to low levels of this attack all the time, 
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but only cells that cannot inactivate the early steps of the cascade, C3b convertase formation, 
are killed. Cells that are destined to become transformed and escape the complement system 
may up-regulate genes that help to control this aspect of immune surveillance. The ability to 
bind and use the natural alternate complement pathway (ACP) inhibitory actions of Factor H 
would be one method of escape. Factor H inhibits the production of C3b by inhibiting the 
binding of Factor B to membrane-bound C3b, thereby preventing cleavage of B to Bb and 
production of the C3 convertase, C3b2b. Factor H also accelerates Factor I-mediated 
cleavage of C3b and sterically inhibits C5 binding to C3b (Bozas et al. 1993). 
 Findings from a number of studies have shown that some of the SIBLING proteins 
are expressed by malignant tissue and trophectoderm and along the fetal-maternal interface 
(Bianco et al. 1991, Rowe et al. 2000, Hotte, 2002, Burghardt et al. 2002, Johnson et al. 
2003c, Fisher et al. 2004). In fact, trophoblasts and metastasizing cancer cells are exposed to 
the highest levels of complement because they are in direct contact with host blood. To 
survive, trophoblasts and neoplasms need to directly control the complement activity on their 
surfaces and thus aid their escape not only from direct lysis but also from being opsonized by 
the alternative complement pathway. Additionally, macrophages, the effector cells in 
immune surveillance, are activated by the alternate complement pathway. Thus, agents that 
inhibit or down-regulate complement decrease both the direct lysis pathway of complement 
as well as macrophage activation, and potentially promote trophectoderm and tumor cell 
survival (Mevorach et al. 1998). The expression of SIBLING proteins in tumor and /or 
trophectoderm cells could provide such a selective advantage for survival. In this regard, 
some SIBLING members have been reported to bind strongly to Factor H and block the lytic 
activity through either the v3 integrin or CD44.  Binding of Factor H to SPP1, BSP or 
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DMP1 was localized to the cell surface and all three proteins were shown to act in 
conjunction with Factor I, a serum protease that, when complexed to appropriate cofactors 
will lead to digestion of the bound C3b in a series of proteolytic steps and that will result in 
sequestration of Factor H to the cell surface and inhibition of complement-mediated cell lysis 
(Fedarko et al. 2000, Jain et al. 2002). 
 
SIBLINGs and integrins  
Integrins are a large family of heterodimeric transmembrane glycoproteins that attach 
cells to extracellular matrix proteins (Hynes 1992). The central role of integrins in the 
implantation adhesion cascade is thought to stem from their ability to bind ECM ligand(s) to 
mediate adhesion, cause cytoskeletal reorganization to stabilize adhesion, and transduce 
cellular signals through numerous signaling intermediates (Burghardt et al. 1997, Johnson et 
al. 2001). Integrins consist of non-covalently linked α and β subunits, each of which has a 
relatively large extracellular and a short cytoplasmic domains connected by a transmembrane 
segment. The N-terminal domains of the α and β subunits associate to form the integrin 
headpiece which contains the ligand binding site. The C-terminal segment traverses the 
plasma membrane and this portion of the  subunit mediates interaction with the cytoskeleton 
as well as with the signaling proteins (Giancotti 2003). Integrins can mediate “outside-in” 
and “inside-out” signaling in two processes referred to as signaling and activation, 
respectively (Giancotti and Ruoslahti, 1999). Ligand binding through an integrin receptor 
results in specific effects on cytoskeletal organization and activation of signaling pathways 
which lead to regulation of gene expression. In addition, integrin cytoplasmic domains 
transduce cell type-specific signals that modulate ligand binding affinity (Burghardt et al. 
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2002). Many members of the integrin family, including 51, 81, IIb3, v3, v5, 
v6 and v8, recognize an Arg-Gly-Asp (RGD) motif within their ligands. These ligands 
include Fn (fibronectin), fibrinogen, vitronectin, SIBLING proteins, and many other large 
glycoproteins. In fact, peptides containing this motif can efficiently block these integrin-
ligand interactions (Fisher & Fedarko 2003, Takagi 2004). The RGD sequence is a very 
important functional motif found in all members of the SIBLING family (Fisher et al. 2001). 
SPP1, and presumably other SIBLINGs have additional non-RGD integrin binding sequences 
which suggests additional integrin-SIBLING interactions.  
In the reproductive tract, some members of the integrin family have been reported to 
have spatial and temporal relationships with blastocyst development and implantation 
(Burghardt et al. 1997). Many unexplained cases of infertility in human are accompanied by 
abnormal expression of integrins (Lessey & Castelbaum 2002). The integrin family 
represents a clear example of a set of genes with potentially overlapping functions. Most 
integrin ligands can be bound by multiple integrins and most integrins can bind more than 
one ligand (Hynes 1992). Furthermore, since integrins are α and β heterodimers, ablation of 
the gene for a single subunit usually has effects on other subunits, therefore the null 
mutations of either subunit for some integrins leads to peri-implantation lethality (Hynes 
1996).  
During the periimplantation period of pregnancy in ewes, integrin subunits α (v, 4, 5) 
and β (1, 3 and 5) were found to be constitutively expressed on the apical surface of the LE 
and were not influenced by pregnancy or presence of the conceptus. Moreover, these 
subunits were also detected on the apical surface of conceptus trophoblast (Johnson et al. 
2001). Therefore, in the sheep, receptivity to implantation does not appear to involve changes 
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in either temporal or spatial patterns of integrin expression, but may depend on expression of 
other glycoproteins and ECM proteins, such as galectin-15, SPP1 and fibronectin, which are 
ligands for heterodimers of these integrins (Johnson et al. 2003a, Gray et al. 2004). In 
addition, down regulation of the anti-adhesive MUC1 and/or other mucins may remove a 
barrier that sterically hinders the ability of integrins and other glycoproteins to interact with 
counter receptors or extracellular matrix proteins at the maternal-conceptus interface (Aplin 
et al. 2001, Brayman et al. 2004). 
In the pig, both the conceptus and uterine LE express a number of common integrin 
subunits including α1, α3, α4, α5, αv, β1, β3, and β5, and of these, the α4, α5, αv, β1, β3 
and β5 subunits are detected at sites of initial attachment between uterine LE and 
trophectoderm on Days 12-15 of pregnancy. Additionally, α4, α5, and β1 are modulated 
during the estrous cycle and exhibit a similar expression pattern in ovariectomized gilts 
receiving P4 or P4 plus E2 replacement therapy (Bowen et al. 1996, Burghardt et al. 1997). 
 
Fibroblast Growth Factors 
Fibroblast growth factors (FGFs) are small polypeptide growth factors, all of which 
share common structural characteristics, and most of which can bind to heparin and to 
heparan sulfate moieties of cell surface and extracellular matrix heparan sulfate 
proteoglycans (HSPGs). However, many FGFs contain signal peptides for secretion and are 
therefore secreted into the extracellular environment (Powers et al. 2000). In addition, FGFs 
bind specific receptor tyrosine kinases, i.e., fibroblast growth factor receptors (FGFRs), that 
induce receptor dimerization and kinase activation, ultimately resulting in the activation of 
various signal transduction cascades which are implicated in diverse functions including 
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morphogenesis, cellular differentiation, angiogenesis, tissue remodeling, inflammation, and 
oncogenesis (Powers et al. 2000, Kim 2001). To date, twenty-two distinct FGFs have been 
discovered, numbered consecutively from 1 to 22 that range in molecular mass from 17 to 34 
kDa, and share 13–71% amino acid sequence identity. FGFs can be classified into several 
subfamilies, according to sequence homology within a conserved 120-amino acid core (Kim 
2001). 
  One of the FGFs, FGF7 also known as keratinocyte growth factor, has been detected 
in the uterine wall of primate and subprimate species (Pekonen et al. 1993, Matsui et al. 
1997, Slayden et al. 2000, Ka et al. 2000). Due to the high level of identity of FGFs in their 
structural and biological properties, FGF7 has been placed in an FGF subfamily that includes 
FGF10 and FGF22 (Emoto et al. 1997, Igarashi et al. 1998, Umemori 2004). FGF7 was first 
isolated as an epithelial cell mitogen from the conditioned medium of the human embryonic 
lung fibroblast cell line, M426 (Rubin et al. 1989). Later, stromal cells from a variety of 
sources were found to express FGF7 in culture. These included fibroblasts from human lung, 
skin, mammary gland, stomach, bladder, prostate (Rubin et al. 1995), and smooth muscle 
cells (Winkles et al. 1997).  
Initially, FGF7 was shown to stimulate DNA synthesis in BALB/MK mouse 
keratinocytes and subsequently exhibited mitogenic activity for a wide variety of epithelial 
cells (Rubin et al. 1989, 1995). It had long been postulated that epithelial cell proliferation 
during development as well as in adult organs was mediated by diffusible substances released 
from the underlying mesenchymal tissue (Cunha et al. 1983, Schor & Schor 1987). The 
combination of FGF7 expression by stromal cells in most of the tissue types and cultures and 
its activity specifically on epithelial cells supported the hypothesis that FGF7 functioned as a 
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paracrine mediator of mesenchymal-epithelial communication (Finch & Rubin 2004). 
Neonatal mice, injected with FGF7 showed a 5- to 6-fold increase in uterine epithelial 
growth (Hom et al.1998).  
 In sheep uterus, FGF7 is expressed in the developing neonatal and in adult ovine 
uterus (Chen 2000, Taylor et al. 2001). In adult ewes, the spatial pattern of FGF7 expression 
showed that this protein is located to the deeper layers of the uterine stroma in cyclic and 
pregnant animals which led the authors to hypothesis that FGF7 is a factor that functions in 
regulating development of deeper uterine glands (Chen et al. 2000). Moreover, FGFR2IIIb 
mRNA was also localized by in situ hybridization at the LE during the estrous cycle and 
pregnancy in adult ewes; and semiquantitative RT-PCR analyses indicate that expression of 
FGFR2IIIb and FGF-7 mRNA is constitutive during the estrous cycle and pregnancy. Based 
on these results, it is not clear if any of the female sex steroids have any effect on the 
expression of these two genes (Chen et al. 2000). However, in the porcine uterus FGF7 
mRNA expression was localized in endometrial epithelia and FGF7 receptor, FGFR2IIIb, 
expression was also localized in endometrial epithelia and conceptus trophectoderm, 
suggesting that FGF7 mediates an epithelial-epithelial interaction in an autocrine and/or 
paracrine manner in the pig uterus (Ka et al. 2000).  
 
Fibroblast growth factor receptors 
FGF activity on responsive cells is mediated by a family of high-affinity tyrosine 
kinase receptors, fibroblast growth factor receptors (FGFRs) that are encoded by four 
structurally related genes (FGFR1–4) (Ornitz et al. 1996, Beer et al. 2000). FGFRs contain 
an extracellular ligand binding domain, a single transmembrane domain, and an intracellular 
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tyrosine kinase domain. The extracellular domain determines ligand binding specificity and 
mediates ligand-induced receptor dimerization and contains three immunoglobulin-like (Ig-
like) domains (Lee et al. 1989). Dimerization, in turn, results in one or more trans-
phosphorylation events and the subsequent activation of the receptor (Ornitz et al. 1996). 
Indeed, the specificity of FGF-FGFR binding is determined in part by alternative exons 
corresponding to the carboxy terminal half of the third Ig domain and an adjacent ~20 
residues of downstream sequence in FGFRs. These alternative exons, designated IIIa, IIIb, 
and IIIc, generate receptor variants with different ligand-binding properties (Powers et al. 
2000). 
Expression cloning of the FGF7 receptor revealed that it was encoded by IIIb variants 
of the BEK/FGFR2 gene (FGFR2IIIb) (Miki et al. 1991). Interestingly, binding studies 
demonstrated that FGF7 did not interact with any other FGFR variant (Ornitz et al. 1996). 
However, FGF10 bound preferentially to the FGFR2b receptor variant (Igarashi et al. 1998), 
although it also associated with the IIIb splice variant of FGFR1 (Beer et al. 2000). Although 
the target cell and receptor-binding specificity of FGF22 has not been reported, there is 
speculation that the primary receptor for FGF22 would be the FGFR2b variant as well 
(Umemori et al. 2004). FGFR2b isoforms are found primarily in epithelial cells, and the 
restricted pattern of FGFR2b distribution and remarkable specificity of FGF7 for FGFR2b 
isoforms account for the predominant epithelial activity of FGF7 (Finch & Rubin 2004).   
 
FGF7 and heparin binding 
While FGF family members can be quite divergent in their amino acid sequences and 
expression, binding to heparin and HSPGs is a defining feature of the family. Heparin/HSPG 
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binding has long been recognized to have a major impact on FGF activity. Recent 
crystallographic work showed that heparin molecules stabilize the formation of FGF-FGFR 
complexes by binding both to ligand and receptor molecules (Pellegrini et al. 2000). It has 
been also reported that heparin enhanced the binding of individual FGF and FGFR molecules 
to each other, and facilitated the association of higher order FGF-FGFR complexes 
(Schlessinger et al. 2000). Interestingly, FGF7 binding to FGF2IIIb is enhanced by heparin 
when the level of FGF7 is at physiological concentrations, but binding could be blocked 
when the level of FGF7 is above physiological levels (Berman et al. 1999). Nevertheless, 
HSPGs and heparin are potent modulators of FGF activity. They can protect FGFs from 
thermal denaturation and proteolytic degradation, and binding of FGF to extracellular matrix 
HSPGs provides a reservoir from which FGFs can be rapidly released in response to specific 
triggering events (Saksela 1988, Pineda-Lucena 1994, Berman 1999). 
 
Rationale, Hypotheses and Objectives 
 SIBLING proteins are found in bone and dentin; and are secreted into the 
extracellular matrix (ECM) during the formation and mineralization of these tissues (Fisher 
& Fedarko 2003). Previous studies from sheep, pig, goats and mice (Garlow et al. 2002, 
Johnson et al. 2003c, Joyce et al. 2005, White et al. 2005, 2006) that indicate one SIBLING 
family member (i.e., SPP1) is expressed and functions in the uterus of these animals. 
Therefore, we hypothesized that other SIBLING proteins DSPP, DMP1, MEPE and BSP 
may also be found and function as a matrix protein in the female reproductive tract. Sheep 
were used as a model for our study. Objective 1 of this research was to analyze the 
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expression of extracellular matrix proteins, DSPP, DMP1, MEPE and BSP in the 
endometrium of the cyclic and pregnant sheep.    
 FGF7 has been well characterized as a mesenchymal-released factor that binds to a 
receptor in the epithelium to mediate several functions such as proliferation, differentiation 
and migration (Szebenyi & Fallon 1999). In pigs, it has been shown that FGF7 is synthesized 
by uterine LE and secreted into the uterine lumen where it is hypothesized to bind its 
receptor, FGFR2IIIb, which is found in the LE and TR and act in an autocrine and/or 
paracrine manner to mediate interactions between the uterus and conceptus (Ka et al. 2000). 
In vitro studies using pig endometrial explant cultures, showed that estrogen, but not 
progesterone could increase FGF7 expression (Ka et al. 2001). However, the organ structure 
and multiple cell types of the uterus and the overlapping events of steroid hormones secreted 
from the conceptus and the ovary complicate in vivo gene expression studies, compared to in 
vitro studies. In order to study changes in FGF7 expression in relation to specific or 
combined steroidal treatments, gene expression in the uterus was analyzed by in situ 
hybridization in the context of ER and PR expression. In addition, there is evidence in the 
uterus suggesting that P4 binds PR in stromal cells and induces expression of paracrine 
factors, progestamedins that will then induce gene expression in neighboring epithelial cells 
(Roberts & Bazer 1988). We hypothesized that FGF7 expression in endometrial LE is up-
regulated by estrogen via ER present in endometrial epithelia and progesterone is also 
required as a permissive hormone to allow estrogen to stimulate FGF7 expression or to 
stimulate PR positive stromal cells to release, a yet to be defined, progestamedin which in 
turn will upregulate FGF7 expression in LE. Therefore, Objective 2 of this research was to 
investigate the effects of exogenous steroids (P4 and E2) administration on the expression of 
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FGF7mRNA in ovariectomized pigs and to determine the role of progesterone on the 
expression of FGF7 using the synthetic progesterone antagonist, ZK137, 316. 
 Previous studies showed the critical role of the estrogen in regulating FGF7 in the pig 
uterus in early pregnancy (Ka et al. 2000). In another study the same group showed that E2, 
could increase FGF7 expression in vitro in a dose-dependent manner (Ka et al. 2001). The 
effects of E2 and P4 could be elicited via ER and PR respectively (Cooke et al. 1998a, 
Spencer & Bazer 2002). In the pig, there are several reports regarding ER and PR expression 
in the uterus (Geisert et al. 1993, 1994, Sierralta & Thole, 1996, Sukjumlong et al. 2004, 
Sukjumlong 2005). Although informative, those reports have provided no information 
concerning the endometrial ER and PR expression beyond day 20 of the pregnancy. The 
proposed hypothesis is that both ER and PR expression are similar to early pregnancy and 
that estrogen and progesterone continue to regulate FGF7 expression through out the 
pregnancy. Objective 3 of this research was to study the expression and the cellular 
localization of PR, ER and FGF7 mRNA within the endometrium and placenta of pigs.  
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 CHAPTER II 
EXPRESSION OF SOME MEMBERS OF THE SIBLING PROTEIN 
FAMILY IN THE UTERUS OF SHEEP 
 
 Overview 
The small integrin-binding ligand, N-linked glycoprotein (SIBLING) family of 
genetically related extracellular matrix proteins including secreted phosphoprotein 1 (SPP1), 
dentin matrix protein 1 (DMP1), bone sialoprotein (BSP), dentin sialophosphoprotein 
(DSPP), and matrix extracellular phosphoglycoprotein (MEPE). These proteins are 
somewhat similar in character, being secreted, phosphorylated, and sulfated acidic 
sialoproteins and capable of binding integrins and hydroxyapatite. Members of the family 
have been described as matrix constituents of bone and/or teeth.  One family member, SPP1, 
is more widely expressed and has been observed in a number of epithelial cell types and in 
immune cells. Moreover, some of the SIBLING proteins have been detected in 
nonmineralized tissues including brain, pancreas, kidney and salivary glands. Studies of 
SPP1 in domestic species indicate that stromal SPP1 expression during pregnancy correlates 
with the extent of uterine LE cell displacement and depth of trophoblast invasion during 
implantation. Based upon findings with SPP1, we initiated an analysis of the expression of 
other SIBLING family members in sheep uterus and report here the spatial and temporal 
detection of DSPP, DMP1, MEPE and BSP proteins in the endometrium of cyclic and 
pregnant sheep.  Additionally, sheep were made unilaterally pregnant via ligation of one horn 
and removal of the ipsilateral ovary to generate non-gravid and gravid uterine horns thereby 
allowing investigation of the influence of the conceptus on endometrial expression of 
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SIBLING proteins.  RNA extracted from endometrium of a Day 40 pregnant sheep was 
reverse transcribed into cDNA using random DSPP primers and the enzyme SuperScript III 
RT. The cDNA was amplified and the PCR product was subcloned and sequenced, and the 
blasting results showed 94%, 86% and 84% identities to cow, pig and dog DSPP mRNA 
respectively.  Frozen sections of ovine uterine cross sections obtained from cyclic pregnant 
and unilaterally pregnant sheep were processed for immunofluorescence staining using rabbit 
antisera to the SIBLINGs. DSPP staining was first detected on LE of Day 15 cyclic and 
pregnant animals. In pregnant animals, starting from Day 20 DSPP expression was restricted 
to the stratum compactum stroma, increased by Day 30 and remained prominent in 
caruncular and intercaruncular stroma through Day 120 of pregnancy.  Stromal staining was 
not detected in cyclic sheep.  DSPP expression in the gravid horn of unilaterally pregnant 
sheep was dramatically upregulated as compared to the non-gravid horn. DMP1 and MEPE 
proteins were constitutively localized to the stroma of cyclic and pregnant ewes while no 
BSP was detected. These studies indicate that DSPP protein is upregulated in conjunction 
with pregnancy-related stromal changes and matrix remodeling in sheep and upregulated 
under the influence of the conceptus. Moreover we also reported the presence of DMP1 and 
MEPE proteins in the stratum compactum stroma of the ovine uterus. We hypothesize that 
the SIBLING proteins DSPP and SPP1 increase in the stroma of pregnant sheep as part of a 
uterine response to implantation and placentation. The role of DMP1 and MEPE are 
unknown but might be important to limit the invasive migration of trophoblast cells. 
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Introduction 
 The small integrin-binding ligand N-linked glycoprotein (SIBLING) gene family 
includes DSPP, DMP1, BSP, MEPE, and SPP1 (also known as osteopontin).  A sixth protein, 
enamelin (ENAM) has recently been identified as a more distant member of the family. 
(Fisher & Fedarko 2003). SIBLING proteins are found in the bone and dentin and are 
secreted into the extracellular matrices (ECM) during the formation and mineralization of 
these tissues (Butler et al. 2002; Fisher & Fedarko 2003). SPP1 DMP1, BSP, DSPP, and 
MEPE are clustered within a 375 kb region of human chromosome 4q21, on chromosome 14 
of the rat, and chromosome 5 of the mouse.  Moreover, SIBLNG genes have similar exon 
structures, e.g.,  exon 1 is always noncoding, exon 2 is the leader sequence and the first two 
amino acids of the mature protein, exon 3 and 5 usually contains the consensus sequence 
(SSEE) for casein kinase II (CKII) phosphorylation, exon 4 is usually proline-rich, and 
among the acidic proteins, is the only significantly positive-charged domain while the 
majority of each protein is encoded by the last one or two exons and contains the integrin-
binding tripeptide  Arg-Gly-Asp (RGD) (Huq et al. 2005).  
 DSPP is a compound gene encoding for two proteins, namely dentin sialoprotein 
(DSP) and dentin phosphoprotein (DPP) (also known as phosphophoryn, PP) (MacDougall et 
al. 1997). The DSPP gene undergoes several post-transcriptional modifications such as 
alternative splicing as several transcripts of various length have been identified (Yamakoshi 
et al. 2003). There is also speculation that after post-translational modification, DSPP is 
synthesized as a “pro” form and may be proteolytically cleaved to DSP and DPP moieties 
(Ritchie & Wang 2000).  DMP1 was first discovered by cDNA cloning with the use of a rat 
odontoblast mRNA library (George et al. 1999). Because DMP1 contains large number of 
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acidic domains, DMP1 was initially thought to participate only in matrix mineralization.  
However, more recent studies have indicated that DMP1 may act as a transcription factor for 
activation of osteoblast-specific genes like osteocalcin and as a regulator of DSPP 
(Narayanan et al. 2003, 2006).  BSP was first purified and characterized from fetal calf bone 
(Fisher et al. 1983) and has been shown to be involved in cell attachment, cell signaling, 
hydroxyapatite binding, hydroxyapatite nucleation and collagen binding (Ganss et al. 1999). 
MEPE was first described in bone marrow and tumors causing osteomalacia as tumor-
secreted phosphaturic factor (Rowe et al. 2000, 2005). The best known SIBLING family 
member is SPP1 which was first described as a bone matrix protein (Prince et al. 1987) but 
has since been described in a wide variety of tissues. 
 While SIBLING protein expression was initially associated with cells that produce 
mineralized extracellular matrix and were hypothesized to play a role in mineralization, it 
was soon recognized that members of this protein family are also produced in 
nonmineralized tissues.  For example, while SPP1 was identified as a bone matrix protein, it 
was independently identified as 2ar, a product inducible by tumor promoters and growth 
factors in a variety of cultured mouse cell lines (Smith and Denhart, 1987) and as early T 
lymphocyte activation 1 (ETA-1) a protein that is abundantly expressed after activation of T 
cells (Patarca 1989).  Later, SPP1 was found to be deposited as a prominent layer at the 
luminal surfaces of specific populations of epithelial cells of the gastrointestinal tract, gall 
bladder, pancreas, urinary and reproductive tracts, lung, breast, salivary glands, and sweat 
glands (Brown et al. 1992).  It has recently received considerable attention as an extracellular 
matrix protein present in multiple tissue-level compartments of the uterus where it may 
participate as a critical role in implantation, stromal differentiation, and placentation 
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(Johnson et al. 2003c).  The multiple functional roles of SPP1 in the uterus are thought to 
result from both the spatial temporal patterns of expression and the posttranslational 
modifications of the protein (Johnson et al. 1999a, 1999b, 2003a, 2003b, 2003c, White et 
al.2006). 
  Similarly, other SIBLING family members, including DMP1, BSP, DSPP, and MEPE 
have been identified in a wide variety of non-mineralizing tissue (Rowe et al. 2000, 
Terasawa et al. 2004; Ogbureke & Fisher, 2004, 2005). Bianco et al. 1991 also reported the 
expression of BSP in the TR of human placenta.   Therefore in light of the growing evidence 
for the expression of SIBLING proteins in diverse tissue types and the expression of SPP1 
expression throughout pregnancy in the uterus, the expression of other SIBLING proteins 
was analyzed in cyclic and pregnant ovine uterus.  We report here, initial findings relative to 
expression of DSPP, DMP1, BSP and MEPE in the ovine uterus. 
 
Materials and Methods 
Animals and tissue collection 
 All experimental and surgical procedures complied with the Guide for Care and Use 
of Laboratory Animals and were approved by the Agricultural Animal Care and Use 
Committee of Texas A&M University.  Mature western range ewes (n=64) were observed 
daily for estrous behavior using vasectomized rams. After experiencing at least two estrous 
cycles of normal duration (16–18 days), animals were assigned randomly on Day 0 
(estrus/mating) to cyclic or pregnant status. For pregnancy, ewes were bred to intact rams at 
estrus (day 0) and 12 h and 24 h after the onset of the estrus. Ewes were randomly assigned 
to be hysterectomized (n = 4 ewes/day) on Days 10, 13, or 15 of the estrous cycle and Days  
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13, 15, 20, 25, 30, 35, 40, 45, 50, 60, 80, 100 and 120 of pregnancy. Days of hysterectomy 
were chosen to represent previously defined morphological and developmental changes in 
intercaruncular and caruncular regions of the uterus during pregnancy in sheep. Pregnancy 
was confirmed by the presence of an apparently normal conceptus in uterine flushes (Days 11 
and 15), or the presence of conceptus tissue on Days 20 through 120. 
 Another group of ewes was made unilaterally pregnant in order to further evaluate the 
local effect of the conceptus on SIBLING proteins that might be expressed exclusively in 
pregnant animals based upon previous findings of SPP1 (Johnson et al. 2003c).  In this 
model, one uterine horn was manipulated to produce a non-gravid horn while the other 
uterine horn remained unmodified to supply the pregnancy with normal placentation (Bazer 
et al. 1979). Sexually mature ewes (n = 3) were checked daily for estrous behavior as 
described above. Following a second estrous cycle of normal duration, the ovary ipsilateral to 
the right uterine horn was removed. A double ligature was placed on the base of the right 
uterine horn at the uterine bifurcation. At the following estrus (Day 0), ewes were mated to 
intact rams. Ewes were then hysterectomized on either Day 40, 80 or 120 of gestation. 
 At hysterectomy, several sections (~0.5 cm3) from the middle of each uterine horn 
were fixed in 4% paraformaldehyde in PBS (pH 7.2) and were embedded in Paraplast-Plus 
(Oxford Laboratory, St. Louis, MO). In addition, several other sections were embedded in 
Tissue-Tek Optimal Cutting Temperature (OCT) compound (Miles, Oneonta, NY), snap-
frozen in liquid nitrogen, and stored at -80oC until analysis.  
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Immunocytochemical analyses 
 Localization of DSPP, DMP1, BSP and MEPE proteins by immunofluorescence 
microscopy were performed as previously described (Johnson et al. 1999a). Rabbit 
polyclonal antisera to DSPP (LF-151), DMP1 (LF-148), BSP (LF-83) or MEPE (LF-155) 
were a gift of Dr. Larry Fisher, Matrix Biochemistry Laboratory, National Institute of Dental 
and Craniofacial Research, National Institutes of Health.  Details regarding these rabbit 
polyclonal antisera derived against human antigen sequences can be found at Appendix A. 
Frozen sections (~10 m) of endometrium were cut with a cryostat (Hacker-BrightOTF, 
Hacker Instruments, Inc., Winnsboro, SC, USA) and mounted on Superfrost/Plus microscope 
slides (Fisher Scientific, Pittsburgh, PA, USA). Sections were fixed in – 20 ºC methanol for 
10 min, permeabilized at room temperature with 0.3% Tween 20 in 0.02M PBS (rinse 
solution), and blocked in antibody dilution buffer (2 parts 0.02M PBS, 1.0% BSA, 0.3% 
Tween 20 [pH 8.0] and one part glycerol) containing 10% normal goat serum for 1 h at room 
temperature. Sections were then dipped in rinse solution at room temperature and incubated 
overnight at 4 ºC with 2 g/ml of rabbit anti DSPP (LF-151), DMP1 (LF-148), BSP (LF-83) 
or MEPE (LF-155) antibodies. Antibody-protein complex were detected with fluorescein-
conjugated goat anti-rabbit secondary antibody (Chemicon International, Temecula, CA). 
Slides were then overlaid with a coverglass and Prolong antifade mounting reagent 
(Molecular Probes).   
 To support results obtained by immunofluorescence, the expression of DSPP protein 
was evaluated by immunohistochemistry in paraformaldehyde-fixed, paraffin-embedded, 
uterine tissue cross-sections (4 m) using procedures described previously (Spencer et al 
1995a). Briefly, boiling citrate buffer was used for antigen retrieval of DSPP and protein was 
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detected with rabbit anti-human DSPP IgG (2 g/ml; LF-151, a gift from Dr. Larry Fisher, 
NIH) and visualized with a Super ABC Rabbit IgG Kit (Biomeda, Foster City, CA). For 
negative controls for primary antibody staining, primary antibodies were substituted with 
rabbit IgG at the same concentration as the primary antibodies. 
 
DSPP and BSP cDNA cloning  
An ovine DSPP cDNA of 850 base pairs (bp) was amplified as described previously 
(Ka et al. 2000). Briefly, polymerase chain reaction (PCR) was performed with primers to a 
porcine DSPP cDNA sequence (GenBank accession no. AY161862; forward, 5´- 
TTCCAGTTCCTCAAATCAAGC; reverse, 5´ TCCTCTTCATCTGCTCCATTC) and a 
reverse-transcribed template from Day 40 pregnant ovine endometrial total RNA and cloned 
into the pCR II vector (Invitrogen, Carlsbad, CA). A BSP cDNA of 180 bp was amplified 
using PCR with primers to a bovine cDNA sequence (GenBank accession no NM_174084; 
forward, 5´-TGGAGAGGAAGACGGTGAAG; reverse, 5´ TCATTGGTGCCTGTTTGTTC) 
and cloned into the pCR II vector. 
 
Photomicrography 
Digital photomicrographs of representative brightfield illumination 
(immunohistochemistry) images were evaluated with a Zeiss Axioplan2 microscope (Carl 
Zeiss, Thornwood, NY) fitted with an Axiocam HR digital camera.  Digital images of 
immunohistochemistry were recorded using Axiovision 4.3 software. All 
immunohistochemistry figures were assembled using Adobe Photoshop 8.0 (Adobe Systems 
Inc., San Jose, CA). 
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Results 
 Three of four SIBLING proteins (DMP1, MEPE and DSPP, but not BSP) were 
detected in ovine uterus by immunofluorescence analyses. Immunoreactive signals were 
absent in uterine sections in which rabbit IgG replaced primary antibody.   
 
DMP1 and MEPE 
 High levels of immunoreactive DMP1 were localized to the stratum compactum 
stroma of cyclic and pregnant ewes (Fig. 1). The fluorescence intensity of DMP1 staining in 
LE and GE was not detectably different from background levels of staining when primary 
antibody was replaced with irrelevant rabbit IgG (Fig.1).  
 DMP1 was also detected along the endothelial cells lining the blood vessels and the 
allantoic membrane (Fig.2).  Similar to DMP1, immunofluorescence staining for MEPE 
revealed that the protein was constitutively expressed in the stromal layer of both cyclic and 
pregnant ewes while low to undetectable staining was observed in the LE (Fig.3).   
 
DSPP 
 Immunoreactive DSPP was detected in the LE and GE of Day 15 cyclic and pregnant 
ewes by immunofluorescence (Fig. 4).  An identical pattern of staining was observed in 
samples processed for immunohistochemistry using the Super ABC peroxidase kit, data 
shown in Appendix B. DSPP signal in LE and GE was significantly reduced after Day 20 of 
pregnancy, however, staining was detected in cells of the stratum compactum stroma 
increased until Day 40 and remained elevated in the stratum compactum stroma through Day 
120 (Fig. 4). Since DSPP was the only SIBLING protein analyzed in which stromal 
  
Figure 1. DMP1 immunofluorescence staining of endometrium from cyclic and pregnant ewes. Note the strong constitutive DMP1 
expression in the stroma (ST). Normal rabbit IgG serves as a negative control when used in Day 35 pregnant tissue.  LE, Luminal 
epithelium; GE, glandular epithelium; PL, placenta. Width of each field, 330 m. 
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expression was upregulated exclusively during pregnancy, the effect of the conceptus on 
DSPP protein was analyzed.  Immunofluorescence analysis of the unilaterally pregnant 
sheep uterus indicated that DSPP protein in the gravid horn was significantly upregulated 
as compared to the non-gravid horn on Days 40 through 120 (Fig.5). A cDNA for DSPP 
was amplified and the PCR product of 830 bp was subcloned and sequenced and analysis 
of sequence homology indicated 94%, 86% and 84% identities to cow, pig and dog DSPP 
mRNA respectively.  However, the probe failed to provide a detectable signal for in situ 
hybridization analysis.   
 
BSP  
Neither BSP protein nor mRNA was detected in either cyclic or pregnant ovine 
uterus.   
 
 
 
 
Figure 2.  High levels of DMP1 immunoreactivity were detected by immunofluorescence 
in the endothelial cells of the blood vessels (left panel) and in the allantoic membrane 
(right panel). Width of each field, 690 m. 
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Figure 3. MEPE immunofluorescence staining of endometrium from cyclic and pregnant 
ewes. Note the strong MEPE expression in the stroma (ST) of both cyclic and pregnant 
sheep. LE, Luminal epithelium; GE, glandular epithelium; PL, placenta. Width of each 
field, 690 m.  
  
 
Figure 4. DSPP protein expression in ovine endometrium of cyclic (C) and pregnant (P) ewes. DSPP was detected using 
immunofluorescence staining of frozen sections. Note that there was some immunoreactivity at the luminal epithelium, LE of cyclic 
and early pregnant uterus. Stratum compactum stroma, ST, showed progressive increasing immunoreactivity starting from Day 20 
through Day 40 and remained high through Day 120 pregnancy. Normal rabbit IgG serves as a negative control when used in Day 35 
pregnant tissue. PL, placenta. Width of each field, 330 m. 
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Figure 5.  DSPP immunofluorescence staining of endometrium from gravid and non 
gravid horns of Day 40, 80 and 120 pregnant ewes. DSPP expression in the stroma (ST) 
of gravid horns showed increased upregulation in comparison to non-gravid horns 
suggesting potential effects of the conceptus on stromal expression of DSPP.  LE, 
Luminal epithelium. Width of each field, 690 m. 
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Discussion 
 This study presents the first evidence that members of SIBLING proteins other 
than SPP1 are expressed in the ovine uterus suggesting additional roles for these proteins 
in non-mineralized tissues.  While BSP protein or mRNA were not detected in ovine 
uterus, DMP1 and MEPE were present in uterine stroma in cyclic and pregnant sheep and 
the pattern of expression did not change during the cycle and pregnancy.  In contrast, 
DSPP protein exhibited a pattern in uterine stroma that is remarkably similar to that 
previously reported for SPP1 (Johnson et al. 2003a,b). 
 All of the SIBLINGs expressed in ovine endometrium are characterized as being 
secreted, phosphorylated, and sulfated proteins, and with the exception of MEPE, are 
acidic in character (Fisher et al. 2001).  Each of the SIBLINGs contains the integrin-
binding RGD tripeptide, however, the function of most SIBLINGs is poorly understood 
and thus the significance of their expression in ovine uterus remains to be determined.   
 To date the best known and well studied SIBLING member in the female 
reproductive tract of different primate and subprimate species is SPP1.  Comprehensive 
analyses of the temporal and spatial patterns of SPP1 mRNA and protein expression 
within the uteri of multiple species has led to the suggestion that SPP1 has diverse 
biological functions in the uterus throughout the estrous cycle and pregnancy beginning 
at the peri-implantation period and extending to the end of gestation (Johnson et al. 
2003a).  In ovine uterus, at least two different tissue-level compartments express SPP1.  
A 70 kDa full length protein is secreted by uterine glands into the uterine lumen during 
pregnancy under the control of progesterone and is proteolytically cleaved to a 40 kDa 
fragment that persists along the entire maternal/conceptus interface during pregnancy in 
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sheep (Johnson et al. 2003c).  A full length 70 kDa SPP1 is also induced in uterine 
stroma once the conceptus begins to form stable contacts with the uterine LE and 
expression also continues to be present in endometrial stromal throughout pregnancy 
(Johnson et al. 2003a,b,c).   
 Similar to SPP1, it appears that immunoreactive DSPP is present at the surface of 
the LE during the peri-implantation period. It is possible therefore that DSPP in the 
uterine lumen may function in a manner similar to that hypothesized for the 40 kDa SPP1 
protein.  The SPP1 fragment is thought to function as a bridging ligand with 
mechanosensory properties linking apical surfaces of both LE and conceptus 
trophectoderm (Johnson et al. 2003a). 
 The similarity of stromal DSPP immunoreactivity to that of stromal SPP1 is 
striking.  Similarly, results obtained with the unilaterally pregnant sheep model system 
showing that increased DSPP immunoreactivity in the gravid uterine horn compared to 
the non-gravid horn suggests the influence of the conceptus on this response as has been 
found for SPP1 (Johnson et al. 2006).   Stromal DSPP appears to be another marker of 
stromal changes that appear to be associated with a decidualization-like response of ovine 
endometrial stroma (Johnson et al. 2003b) which is also associated with the upregulation 
of the RGD-binding v3 integrin and several proteins regarded as markers of 
decidualization in species with invasive implantation.  The upregulation of both SPP1 
and DSPP may reflect matrix remodeling and changes in the mechanical properties of the 
stroma needed to accommodate tension and shear forces that increase during pregnancy.  
Studies are needed to determine how these SIBLINGs influence mechanical properties of 
the uterine stroma during pregnancy.  In addition, several SIBLING members including 
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SPP1 have been shown to bind and activate matrix metalloproteinases (MMP) (Fedarko 
et al. 2004). Several MMPs including MMP-1, -2, -3 and -9 (Salamonson et al.  1991, 
1993, Vagoni et al. 1998) have previously been reported to be secreted by ovine 
endometrial cells and placenta.  To date, however, no specific MMP has been associated 
with DSPP (Fedarko et al. 2004) nor has any SIBLING protein been directly associated 
with any MMP in ovine uterus.  Further studies are needed to evaluate possible 
relationships between ovine uterine SIBLING proteins and MMPs.   
 The detection of DMP1 and MEPE in cyclic and pregnant ovine endometrial 
stroma is novel.  As noted previously, several SIBLINGs expressed in non-mineralizing 
tissue including BSP, DMP1 and SPP1 binds with high affinity and specifically activates 
proMMP-2, proMMP-9 and proMMP-3 respectively.  Additionally, these same proteins 
bind to complement Factor H with even higher affinity (Fedarko et al. 2004).  
Interactions among DMP1, pro-MMP9 and Factor H are hypothesized to influence 
activation of MMPs to effect local turnover of ECM.  A role for DMP1 in the local 
activation of MMPs in ovine uterine stroma remains to be evaluated.   
 MEPE is the most recently identified member of the SIBLING family initially 
identified as a dentin/bone protein regulating mineralization (Fisher & Fedarko 2003) but 
more recently found in salivary gland and kidney (Ogbureke & Fisher 2004) and in 
tumors that exhibit altered phosphate homeostasis (Berndt & Kumar 2006).  While no 
specific MMP partner for MEPE has been identified to date, it is speculated that this 
SIBLING may also play a role in MMP regulation. 
 In summary, this is the first identification of three new SIBLING family members 
in ovine uterus, however, the functional role of these ECM proteins remains to be 
 44 
determined.  Future challenges are to determine: a) whether any of the SIBINGs 
expressed in ovine uterus are associated with MMP partners, b) specific integrin partners 
that are capable of binding each of the SIBLINGS, and c) the potential 
mechanosensory/mechanotransduction roles of these SIBLINGs, particularly DSPP, in 
endometrial function. 
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CHAPTER III 
REGULATION OF FIBROBLAST GROWTH FACTOR 7 IN THE 
PIG UTERUS BY PROGESTERONE AND ESTRADIOL 
 
Overview 
Fibroblast growth factor 7 (FGF7) stimulates cell proliferation, differentiation, 
migration and angiogenesis.  The consensus has been that FGF7 is expressed by 
mesenchymal cells and acts via FGF receptor 2IIIb (FGFR2) on epithelia to mediate 
epithelial-mesenchymal interactions.  The pig uterus is unique in that FGF7 is expressed 
by LE and FGFR2 is expressed on LE, glandular epithelium (GE) and trophectoderm to 
effect proliferation and differentiated cell functions during conceptus development and 
implantation.  FGF7 expression by uterine LE of pigs increases between Days 9 and 12 
of the estrous cycle and also pregnancy as concentrations of progesterone increase, 
progesterone receptors (PGR) in uterine epithelia decrease and conceptuses secrete 
estradiol for pregnancy recognition.  Further, estradiol increases expression of FGF7 in 
epithelial cells of pig uterine explants.  This study investigated involvement of 
progesterone and estradiol and their receptors on expression of FGF7 in the pig uterus in 
vivo.  Pigs were ovariectomized on Day 4 of the estrous cycle and injected i.m. daily 
from Days 4-12 with either corn oil (CO), progesterone (P4), P4 and ZK317,316, a PGR 
antagonist, (PZK), estradiol-17 (E2), P4 and E2 (PE), or P4 and ZK and E2 (PZKE).  
All gilts (n = 5/trt) were hysterectomized on Day 12.  In the absence of P4 and E2, the LE 
of CO-treated pigs expressed PGR which precluded expression of FGF7 mRNA.  In P4-
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treated pigs, PGR were down-regulated in LE, but maintained in stromal cells, allowing 
production of a putative progestamedin from stromal cells to induce FGF7 in LE.  For 
pigs treated with PZK, uterine PGR are not functional in stromal cells which precluded 
P4-induction of a progestamedin to stimulate expression of FGF7 in LE.  Injection of E2 
alone did not induce FGF7 in LE because LE was PGR-positive. However, treatment 
with PE allowed both down-regulation of PGR and induction of FGF7 in LE via either 
direct effects of E2 via estrogen receptor alpha (ESR1), effects of a progestamedin, or a 
combination of those events.  Finally, LE of pigs treated with PZKE expressed FGF7 
indicating that E2 can directly induce FGF7 expression in the absence of functional PGR.   
These results suggest that: 1) P4 is permissive to FGF7 expression by down-regulating 
PGR in LE; 2) P4 stimulates PGR positive uterine stromal cells to release an unidentified 
progestamedin that induces FGF7 expression by LE; 3) E2 and P4 can induce FGF7 
when PGR are rendered nonfunctional by ZK and 4) E2 from conceptuses interacts via 
ESR1 in LE to induce maximal expression of FGF7 in LE on Day 12 of pregnancy in 
pigs.    
 
Introduction 
Fibroblast growth factor 7 (FGF7), also called keratinocyte growth factor, is a 
member of the FGF superfamily which has been reported to stimulate cell proliferation, 
differentiation, migration and vascular angiogenesis (Szebenyi & Fallon 1999).  The 
preponderance of studies show that FGF7 is expressed in cells of mesenchymal (stromal) 
origin.  However, FGF7 receptors (FGF receptor 2IIIb, FGFR2) are present only on 
epithelial cells (Rubin et al. 1995).  Therefore, the prevailing opinion is that 
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mesenchymal-derived FGF7 binds receptors on epithelia to mediate epithelial-
mesenchymal interactions in various organs, including the reproductive tract (Rubin et al. 
1995, Cooke et al. 1998b).  In sharp contrast to this consensus opinion, results of these 
studies demonstrated that FGF7 mRNA is expressed in endometrial epithelia of pigs, that 
FGFR2 mRNA is present in both the endometrial epithelia and conceptus trophectoderm, 
and that FGF7 stimulates trophectoderm, but not endometrial epithelial cells, to undergo 
proliferation and differentiation, suggesting that FGF7 is a paracrine mediator of 
interactions between the uterus and conceptus (Ka et al. 2000, 2001, Ka & Bazer 2005).  
Several factors including cytokines, growth factors and hormones, are known to 
affect FGF7 expression in various tissues.  Interleukin-1, interleukin-6, platelet-derived 
growth factor- and transforming growth factor-  increase FGF7 mRNA expression [7, 
8] (Chedid et al. 1994; Li & Tseng 1997). Parrott and co-workers (2000) showed that 
FGF7 and hepatocyte growth factor (HGF) stimulate FGF7 expression in ovarian surface 
epithelium via a positive autocrine feedback mechanism.  Steroid hormones also regulate 
FGF7 expression in reproductive organs.  In the uterine endometrium of rhesus monkeys, 
progesterone (P4) increases stromal expression of FGF7 where it may mediate P4-
induced increases in epithelial cell proliferation and spiral artery development (Koji et al. 
1994).  In mice, estrogen increases mammary gland expression of FGF7 where it may 
play a role in gland development (Pedchenko & Imagawa 2000).  Androgens also 
stimulate FGF7 expression in stromal cells of the prostate (Yan et al. 1992).  It is 
significant that the promoter region of the FGF7 gene contains various regulatory factor 
binding sites, including steroid response elements for estrogen and glucocorticoids in 
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humans (Finch et al. 1995, Zhou & Finch 1999) and for androgens in rats (Fasciana et al. 
1996). 
Northern blot and in situ hybridization analyses of FGF7 in pig endometrium 
indicated expression during the estrous cycle and peri-implantation period.  FGF7 
expression was first detected in LE between Days 9 and 12 of both the estrous cycle and 
pregnancy, peaked on Day 12 of pregnancy, and remained high through Day 20 (Ka et al. 
2000).  Because the increase in FGF7 expression on Day 12 of pregnancy was 
significantly amplified over Day 12 of the estrous cycle, subsequent studies using an 
endometrial explant culture system were performed to determine hormonal and/or 
cytokine regulation of FGF7.  In these studies, estradiol (E2), but not P4, increased FGF7 
mRNA (Ka et al. 2001).  However, the peri-implantation period of pregnancy is highly 
complex, and cannot be duplicated in in vitro culture systems.  In pigs the uterine 
environment is influenced by the overlapping events of E2 release by conceptuses for 
maternal recognition of pregnancy, and by extended exposure to P4, the hormone of 
pregnancy, to mediate developmental changes in the uterus conducive to successful 
implantation and placentation (Bazer & Thatcher 1977, Bazer et al. 1998).  It is known 
that estrogen receptor α (ESR1) is present in uterine endometrial epithelial cells between 
Days 12 and 15 of the estrous cycle and pregnancy in the pig, whereas P4 receptors 
(PGR) are undetectable in epithelial cells (Geisert et al 1993, 1994).  Given that E2 is 
secreted by pig conceptuses into the uterine lumen (Bazer & Thatcher 1977, Bazer et al. 
1998) it is likely that FGF7 expression in LE is up-regulated by E2 via ESR1 present in 
endometrial epithelia.  However, since P4 is the dominant hormone during diestrus of the 
estrous cycle and during pregnancy and FGF7 is expressed by LE between Days 12 and 
 49 
15 of both the estrous cycle and pregnancy, it is possible that P4 is required as a 
permissive hormone to allow E2 to stimulate FGF7 expression by endometrial LE.  
Therefore, we hypothesized that P4 is required as a permissive hormone for E2-induced 
FGF7 expression in LE of pig endometrium and conducted a study to investigate the 
relationship between P4 and E2 and their receptors on FGF7 expression in vivo.
 
Materials and Methods 
Animals and tissue collection 
 All experimental and surgical procedures complied with the Guide for Care and 
Use of Laboratory Animals and were approved by the Institutional Agricultural Animal 
Care and Use Committee of Texas A&M University.  A total of 26 sexually mature gilts 
of similar age, weight and genetic background were ovariectomized on Day 4 after the 
onset of estrus (Day 0) and assigned randomly to be treated daily at 0700 h from Day 4 
through Day 12 with either: 1) progesterone (P4, 200 mg in corn oil vehicle (CO); Sigma, 
St. Louis, MO) alone (5 gilts); 2) P4 plus ZK137,316 (75 mg; ZK, PGR antagonist, 
generously provided by Dr. Kristoff Chwalisz, Schering, AG, Berlin, Germany) (5 gilts); 
3) P4 plus estradiol-17 (E2, 100 g; Sigma) (5gilts); 4) P4 plus ZK plus E2 (5 gilts); 5) 
estradiol benzoate (E2, 5 mg in 5 ml of corn oil/day) (3 gilts) or 6) CO alone (3 gilts). All 
gilts were hysterectomized on Day 12, and uterine flushings obtained by introducing and 
recovering 20 ml sterile saline per uterine horn at hysterectomy.  The flushings were 
clarified by centrifugation (3000 x g for 10 min at 4oC), aliquoted, and frozen at -80oC 
until analyzed.  Several tissue sections (~0.5 cm) from the middle of each uterine horn 
were fixed in 4% paraformaldehyde in PBS (pH 7.2) and embedded in Paraplast-Plus 
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(Oxford Laboratory, St. Louis, MO).  The remaining endometrium was physically 
dissected from the myometrium, frozen in liquid nitrogen, and stored at -80 C for RNA 
extraction.   
 
Northern blot hybridization analyses 
Total cellular RNA was isolated from endometrial tissues using Trizol reagent 
(Invitrogen, Carlsbad, CA) according to manufacturer’s recommendations.    Total 
endometrial RNA (20 ug) was loaded onto a 1.2 % agarose gel, electrophoresed and 
transferred to a 0.2 u nylon membrane as described previously (Spencer & Bazer 1995).  
The blot was then hybridized with [32P]-radiolabeled antisense cRNA probes generated 
from a linearized porcine FGF7 partial cDNA (Ka et. al 2000).  Autoradiographs of 
northern blots were prepared using Kodak X-OMAT x-ray film (Eastman Kodak Co., 
Rochester, NY).   
 
In situ hybridization analyses 
The location of FGF7 mRNA in uterine tissue sections was determined by in situ 
hybridization analysis as described previously (Johnson et al. 1999a).  Briefly, 
deparaffinized, rehydrated, and deproteinated uterine tissue sections (~ 5 m) were 
hybridized with radiolabeled antisense or sense porcine FGF7 cRNA probes that were 
generated from linearized plasmid templates using in vitro transcription with [35S]-UTP 
(Perkin Elmer Life Sciences, Inc).  Plasmid templates were partial cDNAs for porcine 
FGF7 (Ka et al. 2000). After hybridization, washes and digestion with RNase A, 
autoradiography was performed using Kodak NTB-2 liquid photographic emulsion 
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(Eastman Kodak, Rochester, NY).  Slides were exposed at 4oC for 2 wk, developed in 
Kodak D-19 developer, counterstained with Harris modified hematoxylin (Fisher 
Scientific, Fairlawn, NJ), dehydrated through a graded series of alcohol to Citrisolv 
(Decon Laboratories, Inc, King of Prussia, PA) and protected with cover slips.  
 
Western blot analysis 
FGF7 was purified from 1 mg total protein from each uterine flushing by 
incubating with 200 l heparin-beaded agarose (Sigma) at 4oC overnight and washing 
three times with Hank’s balanced salt solution (Sigma; 10,000 x g for 5 min).  Proteins 
bound to heparin-beaded agarose were denatured in Laemmli buffer and separated by 
SDS-PAGE, transferred to nitrocellulose, and blocked with 5% nonfat milk-TBST (Tris-
buffered saline, 0.1% Tween-20) as described previously (Ka et al. 2000).  Blots were 
incubated with a goat polyclonal antibody against human FGF7 synthetic peptide (2 
g/ml; Santa Cruz Biotechnology, Santa Cruz, CA) or normal goat IgG (Sigma) as 
primary antibody in 2% milk-TBST overnight at 4 C, rinsed for 30 min at room 
temperature with TBST, incubated with peroxidase-conjugated rabbit anti-goat IgG 
(1:10,000; Zymed Laboratories Inc., San Francisco, CA) as a secondary antibody for 1 h 
at room temperature, and then rinsed again for 30 min at room temperature with TBST.  
Immunoreactive proteins were detected using enhanced chemiluminescence 
(Amersham/Pharmacia, Arlington Heights, NY) according to the manufacturer's 
recommendations.   
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Immunohistochemistry 
 The expression of PGR and ESR1 proteins was evaluated in paraformaldehyde-
fixed, paraffin-embedded, uterine tissue cross-sections (4 m) using procedures described 
previously (Spencer et al. 1999). Briefly, boiling citrate buffer was used for antigen 
retrieval of PGR, and Pronase E (0.5 mg/ml in PBS) was used to retrieve ESR1 antigen. 
Proteins were detected with mouse anti-human PGR IgG (2 g/ml; 2C5 PGR, Zymed 
Labs, San Francisco, CA) and rat anti human-ESR1 IgG (2 g/ml; H222, Dr. Chris 
Nolan, Abbott Laboratories, Chicago, IL) and visualized with a Super ABC Mouse/Rat 
IgG Kit (Biomeda, Foster City, CA). For negative controls, primary antibodies were 
substituted with mouse (for PGR) or rat (for ESR1) IgG at the same concentration as the 
primary antibodies.  
 
Photomicrography 
 Digital photomicrographs of representative brightfield (immunohistochemistry) or 
brightfield and darkfield illumination (in situ) images were evaluated with a Zeiss 
Axioplan2 microscope (Carl Zeiss, Thornwood, NY) fitted with an Axiocam HR digital 
camera.  Digital images of immunohistochemistry and in situ hybridization were recorded 
using Axiovision 4.3 software. All immunohistochemistry and in situ hybridization 
figures were assembled using Adobe Photoshop 8.0 (Adobe Systems Inc., San Jose, CA). 
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Results 
Steady-State Levels of FGF7 mRNA in Pig Endometrium and FGF7 Protein in the 
Uterine Lumen 
The FGF7 cRNA detected a single transcript of ~ 2.4 kb in northern blot analysis 
of pig endometrial total RNA (Fig. 6).  FGF7 mRNA was detectable in endometria of 
ovariectomized pigs treated with P4 alone, but was not detectable in P4-treated pigs that 
were also treated with ZK, the PGR antagonist.  Results of western blotting to detect 
FGF7 protein purified from uterine flushings using heparin-coated agarose beads are 
shown in Figure 7.  An immunoreactive FGF7 protein of 17-kDa was detected in 
flushings from pigs treated with P4 and E2 and two molecular weight variants of  FGF7 
proteins, 17 kDa and 25 kDa were detected in flushings from pigs treated with P4, E2 and 
ZK indicating secretion of FGF7 into the uterine lumen of pigs (Fig. 7).   
 
 
 
 
Figure 6. Northern blot analysis of FGF7 mRNA (20 g) in endometria from 
ovariectomized pigs treated with progesterone (P4), P4 + estradiol-17 (PE), P4 + 
ZK137,316 (PZK), and PZKE. Positions of the 28S (4.7 kb) and 18S (1.8 kb) rRNAs are 
indicated.  A single transcript of FGF7 (~ 2.4 kb) was detected.  
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Figure 7. Western blot analysis of FGF7 in porcine uterine luminal flushings.  Positions 
of prestained molecular weight standards are indicated. Immunoreactive FGF7 was 
detected (arrows) in uterine flushings from ovariectomized pigs treated with progesterone 
+ estradiol-17β (PE) and P4 + ZK137,316 + E2 (PZKE).  
 
 
 
Interrelationships between FGF7 mRNA, PGR and ESR1 in pig endometrium (Fig. 8) 
In situ hybridization analysis of pig endometrium localized FGF7 mRNA to LE 
of ovariectomized pigs treated with P4, P4 and E2, or P4, E2 and ZK.  However, FGF7 
mRNA was not detected in endometrial LE of pigs treated with CO vehicle, P4 and ZK, 
or E2 alone.  Immunohistochemistry for PGR revealed expression in endometrial LE of 
pigs treated with CO vehicle and also E2, but expression of PGR was absent in LE of 
pigs treated with P4 alone or P4 in combination with either ZK and/or E2.  In contrast, 
PGR was expressed in endometrial stromal cells of pigs in all treatment groups.  
Immunohistochemistry for ESR1 revealed expression in LE, stromal cells and GE of all 
pigs in all treatment groups.  In the following section, the relationships between  
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Figure 8.  Interrelationships between FGF7 mRNA, progesterone receptor protein and E2 
receptor protein in pig endometrium.  First Column: Nuclear immunostaining for ESR1 
protein was detected in luminal (LE), glandular (GE) epithelia (GE) and stromal cells 
(ST) of endometria from all treatment groups. A section from an estradiol valerate-treated 
pig stained with nonimmune rat IgG served as a negative control.  Width of each field, 
540m.  Second Column: Nuclear immunostaining for PGR protein was detected in 
luminal epithelium (LE) of corn oil (CO) and estradiol-17 treated (E2) pigs, whereas 
PGR were present in stroma cells (ST) of endometria from all treatment groups.  A 
section from an E2-treated pig stained with nonimmune mouse IgG (IgG) served as a 
negative control.  Width of each field, 540m.  Third and Fourth Columns: In situ 
hybridization analysis of FGF7 mRNA expression in pig endometrium. The left and right 
panels represent corresponding brightfield and darkfield images, respectively, of 
endometria from each treatment group.  A representative section from a progesterone-
treated pig hybridized with a radiolabeled sense cRNA probe (Sense) served as a negative 
control.   Note that FGF7 mRNA is detectable only in LE and the hybridization signal is 
evident in endometria from pigs treated with progesterone (P4), P4 + estradiol-17  (PE) 
and P4 + ZK 137,316 + estradiol-17 (PZKE) treatments.  Width of each field, 690 m.   
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treatment, PGR and ESR1 status, and FGF7 mRNA expression are summarized by 
treatment group. 
Ovariectomized pigs injected with corn oil (Fig. 8)   
In the absence of ovarian steroid hormones following ovariectomy, the absence of 
P4 and E2 resulted in default expression of both PGR and ESR1 in endometrial LE, 
stromal cells and GE.  The presence of PGR in LE is considered to preclude expression 
of FGF7 mRNA in CO-treated pigs. 
 
Ovariectomized pigs injected with progesterone (Fig. 8) 
Continuous 9 day exposure of pigs to P4 resulted in down-regulation of PGR in 
endometrial LE; but not stromal cells, and did not affect expression of ESR1 in LE, GE 
or stromal cells.  The combined effects of P4-induced down-regulation of PGR in LE 
with maintenance of PGR in stromal cells is considered to  enable P4 to interact with 
PGR in stromal cells to induce synthesis and secretion of a putative progestamedin that 
induced FGF7 in LE. 
 
Ovariectomized pigs treated with progesterone and ZK137,316 (Fig. 8) 
 It appears that PGR in LE and stromal cells are differentially sensitive to effects 
of ZK.  Although ZK did not inhibit P4-induced down-regulation of PGR in endometrial 
LE, ZK bound PGR in endometrial stromal cells to render stromal cell unresponsive to 
P4.  Therefore, it is considered that a progestamedin was not synthesized and released by 
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stromal cells in response to P4 to mediate induction of FGF7 mRNA in LE of pigs 
receiving both P4 and ZK.   
 
Ovariectomized pigs treated with estradiol 17 (Fig. 8) 
The absence of P4 to down-regulate PGR and the effect of E2 to induce PGR, 
resulted in expression of PGR in LE which is considered to prevent induction of FGF7 
mRNA in LE by E2. 
 
Ovariectomized pigs treated with progesterone and estradiol 17 (Fig. 8) 
 Treatment of pigs with both P4 to down-regulated PGR in LE allows E2 to 
induce FGF7 mRNA expression in endometrial LE.  Further, the interaction of P4 with 
PGR in stromal cells is considered to allow induction of a progestamedin that acts on LE 
to induce expression of FGF7 mRNA, or expression of FGF7 mRNA may be induced in 
this treatment group by a combination of these two mechanisms.   
 
Ovariectomized pigs treated with progesterone, ZK and estradiol 17 (Fig. 8) 
The action of ZK on PGR in stromal cells inhibits production of the putative 
progestamedin necessary to induce expression of FGF7 in LE.  Therefore, in the absence 
of functional PGR, E2 acting via ESR1 is considered sufficient to induce expression of 
FGF7 mRNA in pig endometrial LE.   
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Discussion 
The results of the present study in pig endometrium indicate that: 1) P4 is 
permissive to FGF7 expression through its action of down-regulating PGR in LE; 2) P4 
stimulates PGR positive uterine stromal cells to release an as yet unidentified 
progestamedin that induces FGF7 expression by LE; 3) combined effects of E2 and P4 
can induce FGF7 due to the absence of PGR down-regulation by P4 or the presence of 
ZK to block PGR function; and 4) E2 from conceptuses interacts via ESR1 in LE to 
induce maximal expression of FGF7 in LE on Day 12 of pregnancy in pigs.  The 
treatment group receiving both P4 and E2 is most physiological with P4 from the CL 
being permissive to actions of E2 from pig conceptuses during the peri-implantation 
period.  A model summarizing the present working hypothesis for the hormonal 
regulation and role of uterine FGF7 during early pregnancy in pigs is presented in Figure 
9.  The mechanism(s) responsible for lack of expression of FGF7 by endometrial GE is 
not known. 
 Progesterone, the hormone of pregnancy in all mammals, is critical to control 
temporal and spatial (cell-specific) changes in gene expression within the uterus that 
ensure synchrony between uterine and conceptus (embryo/fetus and associated 
membranes) development (Spencer et al. 2004a).  Indeed, treatment with exogenous P4 
significantly alters the expression of a number of genes in rodent, primate and sheep uteri 
as measured by microarray (Ace & Okulicz 2004, Jeong et al 2005, Gray et al. 2006).  
Although similar studies have not been performed in pigs, P4 increases expression of 
calbindin-D9k (Yun et al. 2004), vascular endothelial growth factor (Welter et al. 2003), 
FGF2 and two of its receptors, FGFR1 and FGFR2 (Welter et al. 2004), and 4, 5 and 
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1 integrin receptor subunits (Bowen et al 1996), as well as suppress expression of 
MUC1 (Bowen et al 1996).  Importantly, P4 increases expression of various uterine 
secretory proteins, components of histotroph, hypothesized to support conceptus 
development in pigs (Roberts & Bazer 1988, Simmen et al. 1990, Harney et al. 1993).  
Previous studies with endometrial explant cultures and in vivo steroid replacement 
experiments, failed to demonstrate FGF7 regulation by P4 in the pig uterus because 
investigators assumed that increases in FGF7 expression during the estrous cycle and 
pregnancy were most likely to be influenced by P4 (Ka et al. 2001, Wollenhaupt et al. 
2005).   Results of the present study clearly indicate that FGF7 is induced in the uterine 
LE of ovariectomized pigs treated with P4 and that expression of FGF7 is blocked by ZK, 
a PGR antagonist. 
  The permissive effects of P4 on FGF7 expression are mediated by PGR in pig 
endometrium (Kastner et al. 1990, Cheon et al. 2002).  In most mammalian uteri, PGR 
are expressed in endometrial epithelia and stroma cells during the early to mid-luteal 
phase, allowing direct regulation of genes by P4.  However, in sheep, the presence of 
PGR in LE precludes expression of most P4-regulated genes in LE until continuous 
exposure of the endometrium to P4 down-regulates PGR expression exclusively in LE 
and GE (Spencer et al. 2004b).  This paradigm of loss of PGR in uterine epithelia prior to 
implantation appears to be common across mammals (Carson et al. 2000) and predicates 
that endocrine effects of ovarian P4 on endometrial epithelia during the peri-implantation 
period are mediated indirectly by either P4-indiced paracrine-acting factors 
(progestamedins) produced by the PGR-positive stromal cells, or by induction of factors 
in LE that simultaneously down-regulate PGR and either allow or stimulate expression of 
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endometrial genes (Johnson et al. 2000, Geisert et al 2005).  In pigs, expression of PGR 
in endometrial LE and GE is down-regulated by Day 10 of the estrous cycle and 
pregnancy, whereas expression of PGR is maintained in stromal cells and myometrium 
(Geisert et al. 1994).  Removal of PGR from LE correlates with loss of MUC1 and 
expression of secreted phosphatase 1 (SPP1; also known as osteopontin) on the apical 
surface of LE, exposing integrins to extracellular matrix proteins for trophoblast 
attachment to the uterus (Bowen et al. 1996, White et al. 2005).  This is also the period 
when the endometrium releases many cytokines and growth factors into the uterine lumen 
of pigs to support conceptus development and trophoblast elongation (Geisert & Yelich 
1997).  Although loss of PGR in endometrial epithelia of pigs is well established (Geisert 
et al. 1994), the present results are the first to effectively dissect P4 regulation of gene 
expression in LE during the estrous cycle and early pregnancy.   
Three conclusions can be inferred from results of the present study.  First, similar 
to that reported in sheep (Spencer & Bazer 1995), P4 negatively autoregulates PGR in 
LE, but not PGR in endometrial stromal cells of pigs.   Expression of PGR in LE and 
stromal cells was detected in pigs receiving CO, but was down-regulated in LE of all pigs 
treated with P4.  Second, similar to results for P4-regulated genes in endometrial epithelia 
of sheep (Spencer & Bazer 1995, Johnson et al. 2000), the presence of PGR in pig LE 
precludes induction of FGF7.  All pigs with PGR in LE, i.e., those treated with CO alone 
or E2 alone, failed to express FGF7 in LE.  Third, the combined effects of P4-induced 
down-regulation of PGR in LE and P4 interaction with PGR in stromal cells, resulted 
expression of a putative progestamedin(s) from stromal cells that acted on LE to induce 
FGF7.  Pigs treated with P4 exhibited down-regulation PGR in LE concomitant with 
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induction of FGF7.  Further, FGF7 expression required functional stromal PGR because 
ZK-treatment ablated P4 -induced FGF7 expression.   However, in the absence of 
functional PGR (treatment with P4, E2 and ZK), E2 alone, interacting with ESR1, 
induced FGF7 expression. 
 The mechanisms by which P4 both down-regulates PGR and up-regulates 
expression of other genes within the uterine LE of pigs are not understood.  Induction of 
stromal-derived progestamedins is one explanation for these phenomena; however, an 
attractive alternative hypothesis has been described by Geisert and colleagues (Geisert et 
al. 2005).  They proposed that P4 interacts with PGR in LE to stimulate factors that 
activate nuclear factor kappa B (NF-B) which then functions to both inhibit PGR 
expression and activate transcription of genes believed to be involved with implantation 
(Geisert et al. 2005).  The results of the present study are consistent with either of these 
theories of endometrial gene regulation by P4. 
 Estrogens, secreted by pig conceptuses on Day 12 of gestation, are the maternal 
recognition signal that switches secretion of endometrial prostaglandin F2 from an 
endocrine to exocrine direction to prevent CL regression (Bazer & Thatcher 1977).  In 
addition, conceptus estrogens modulate uterine gene expression to support uterine 
secretions and the controlled inflammatory-like events that characterize changes in 
conceptus morphology and uterine remodeling for implantation in pigs (Geisert et al. 
1982b).  Indeed, secreted SPP1 is induced by estrogen in LE, and initially localizes to LE 
in close proximity to the Day 12 implanting conceptus (White et al. 2005), whereas 
conceptus secretion of estrogens correlates with conceptus secretion of interleukin-1 beta 
(IL1B) and may modulate uterine responses to this cytokine (Ross et al. 2003).  The 
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importance of estrogen to early survival of pig conceptuses is underscored by pregnancy 
loss in response to premature exposure of the pregnant uterus to estrogen.  Administration 
of estrogen on Days 9 and 10 of pig pregnancy is associated with altered expression of 
SPP1 and cyclooxygenase 1 in LE (Geisert et al. 2005, Ashworth et al. 2006), and 
degeneration of conceptuses by Day 15 (Morgan et al. 1987).  In pigs, ESR1 are readily 
detectable in LE from Days 5 through 12 of the estrous cycle and pregnancy, then 
decrease, but remains detectable until Day 15 (Geisert et al. 1993).  The presence of 
ESR1 on LE provides a mechanism by which secretion of estrogen by the elongating pig 
conceptus can stimulate changes in uterine function necessary for maintenance of 
pregnancy (Geisert et al. 1993).  Previous reports, using endometrial explant culture and 
in vivo steroid replacement experiments, strongly suggested that induction of FGF7 in 
uterine LE during early pregnancy in pigs is stimulated primarily by conceptus estrogens 
(Ka et al. 2001, Wollenhaupt et al. 2005).   Results of the present study support previous 
reports and further indicate that FGF7 is induced in the uterine LE of ovariectomized pigs 
injected E2, but only when progesterone has down-regulated PGR in LE.  The uterine LE 
of pigs treated with E2 alone does not express FGF7 mRNA, likely due to the lack of 
progesterone to down-regulate PGR in LE, whereas pigs treated with a combination of E2 
and P4 exhibit FGF7 expression.  Further, functional stromal PGR, and therefore 
progestamedins, are not required for E2 induction of FGF7 because the addition of ZK 
did not alter effects of the combination of P4 and E2. 
 There is a discrepancy between results of the present study and previous reports 
that estrogen in the absence of progesterone can increase endometrial expression of FGF7 
(Ka et al. 2001, Wollenhaupt et al. 2005).  The study by Ka et al (2001) used endometrial 
 64 
explant cultures from Day 9 of the estrous cycle, a day when PGR are significantly 
reduced compared to Days 0 to 5 (Geisert et al. 1994, Sukjumlong et al. 2005).  It is 
likely that PGR were already decreased to levels inadequate to prevent induction of 
FGF7.  Although the study by Wollenhaupt et al. (2005) employed ovariectomized 
steroid-replaced pigs and detected a significant increase in endometrial FGF7 mRNA in 
response to estradiol benzoate over progesterone treatment, levels of expression of FGF7 
mRNA overlapped between gilts treated with vehicle and estradiol benzoate.  Further, 
effects of estradiol benzoate alone did not differ from the combined effects of 
progesterone and estradiol benzoate which did not differ from treatment with either 
vehicle or progesterone alone on FGF7 expression.  Interestingly, increases in FGF7 
protein were detected primarily in the vascular smooth muscle cells and endothelium, 
whereas weak expression in LE was not affected due to the different treatments 
(Wollenhaupt et al. 2005).  In contrast, the present study utilized ZK, a PGR antagonist, 
to dissect the hormonal regulation of FGF7 and in situ hybridization analyses to 
understand cell-specific changes in FGF7 expression.   The results clearly indicate the 
complex and overlapping regulation of FGF7 in endometrial LE by P4 and E2.      
The FGF7 synthesized and secreted by uterine epithelial cells into the uterine 
lumen can stimulate proliferation and differentiation of conceptus trophectoderm (Ka et 
al. 2000, 2001) by influencing DNA synthesis, as well as motility, differentiation, 
cytoprotection and antiapoptotic effects on cells (Finch et al. 1989).  Western blotting 
detected an immunoreactive FGF7 protein of about 25-kDa only in uterine flushings of 
pigs treated with E2.  Interestingly, a 17-kDa FGF7 protein was also detected in uterine 
flushings which may be a cleavage fragment of the native 25 kDa FGF7 protein.  These 
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results indicate that E2 regulates secretion of FGF7 from LE cells.  It is known that 
estrogens of conceptus origin or administered exogenously induce pseudopregnancy, 
modulate redirection of PGF2α secretion from primarily endocrine into the underlying 
vasculature to exocrine into the uterine lumen (Bazer & Thatcher 1977), and increase 
secretory activity of endometrial epithelia directly or by increasing uterine expression of 
prolactin receptors on uterine epithelia (Young et al. 1989).  Therefore, we hypothesize 
that FGF7 secretion is regulated by conceptus estrogens during pregnancy, and ovarian 
estrogens during the estrous cycle.  The detailed cellular mechanism by which estrogen 
affects epithelial FGF7 secretion remains to be determined.  
In summary, the uterine environment of early pregnancy in pigs is complex and 
influenced by overlapping actions of conceptus estrogens for pregnancy recognition in 
concert with permissive effects of P4 acting on uterine epithelia to down-regulate PGR 
and/or via PGR expressed by uterine stromal cells to stimulate expression of a 
progestamedin(s) to mediate developmental changes in uterine functions necessary for 
establishment and maintenance of pregnancy.  The dynamic regulation of FGF7 by 
estrogen and progesterone reflects this complexity, and strongly suggests important roles 
for FGF7 in stimulating proliferation and differentiation of the pig conceptus during 
elongation and implantation.  Results of the present study provide new insights into the 
intricate interplay between the actions of estrogen and progesterone to modify gene 
expression in the peri-implantation pig uterus.  A similar interplay between pregnancy 
recognition signals and progesterone have been reported for sheep (Johnson et al.1999b, 
Song et al. 2005,2006); However, the magnitude and extent of the influence that 
conceptus estrogens impart on the early pregnant uterus are remarkable and unique to the 
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pig.  Clearly, further studies are warranted to further dissect the endocrine and paracrine 
regulation of gene expression in the uterus of pregnant pigs. 
 
 
 
Figure 9.  Schematic illustrating the proposed hormonal regulation of FGF7 expression 
in pregnant uterine endometrium of pigs.  During early pregnancy, continuous exposure 
to progesterone down-regulates progesterone receptor (PGR) in endometrial epithelia to 
remove PGR-dependent inhibition of expression of most progesterone-regulated genes, 
e.g., LE.  Therefore, the endocrine effects of progesterone to induce expression of FGF7 
in endometrial LE and its secretion into the uterine lumen are mediated by paracrine-
acting factors (progestamedins) produced by the PGR-positive stromal cells.  Further, in 
PGR negative epithelial cells, E2, produced by pig conceptuses, binds E2 receptors in LE 
to induce FGF7 expression.  The combined endocrine/paracrine effects of ovarian 
progesterone and conceptus E2 are likely responsible for the high levels of FGF7 
expression in endometria and uterine lumen on Day 12 of pregnancy.  During the estrous 
cycle, FGF7 expression increases in LE during the progesterone-dominated luteal phase, 
whereas maximal levels of FGF7 are attained on Day 12 of pregnancy after PGR are 
down-regulated and when LE is stimulated by both high levels of E2 released by pig 
conceptuses for pregnancy recognition, and progesterone can stimulate secretion of a 
progestamedin(s) by uterine stromal cells.  It is hypothesized that secreted FGF7 acts on 
the conceptus to stimulate proliferation and differentiation of trophectoderm.  
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CHAPTER IV 
ENDOMETRIAL AND PLACENTAL CHANGES IN THE PORCINE 
ESTROGEN AND P4 RECEPTORS DURING PREGNANCY AND 
THEIR ROLE ON FGF7 mRNA EXPRESSION 
 
Overview 
The objective of this study was to investigate the temporal and spatial expression 
of the estrogen receptor (ESR1) and PGR and correlates these to FGF7 expression in the 
uterus from Day 20 through Day 85 of pig pregnancy. As assessed by 
immunohistochemistry, ESR1 was readily detectable in the LE and GE in all days 
examined while PGR was undetectable. However, PGR were more abundant in the 
stromal cells at Day 20 than during later days of pregnancy. The current data showed also 
reduction of FGF7 in LE later in pregnancy. This data suggests that these changes may be 
related to soluble progestamedin levels released by PR positive stromal cells which are in 
turn affected by P4. An interesting finding in this study is the presence of ESR1 in 
placenta of the pig suggesting that estrogen may play important roles in the biology of 
pregnancy through out the gestation in the pig.  
 
Introduction 
Fibroblast growth factor-7 (FGF7) also known as keratinocyte growth factor, was 
originally identified in the conditioned medium of a human embryonic fibroblast cell line 
and identified as a mitogen that is particularly active on keratinocytes and specific for 
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epithelial cells (Rubin et al. 1989). Later studies showed that FGF7 is a paracrine 
mediator of epithelial-mesenchymal interactions in various organs, including those of the 
reproductive tract (Rubin et al. 1995). In the pig, however, it has been shown that FGF7 
is produced and secreted by uterine epithelial cells into the uterine lumen and may 
functions to stimulate the proliferation and differentiation of conceptus trophectoderm 
(Ka et al. 2000). FGF7 expression was first observed in LE on Day 9 of the estrous cycle 
or pregnancy, peaked on Day 12 of pregnancy during a period when the concentrations of 
P4 (P4) increases and conceptuses releases estradiol-17 (E2) for pregnancy recognition 
(Ka et al. 2000). Subsequent studies using an endometrial explant culture system were 
performed to determine hormonal and/or cytokine regulation of FGF7.  In these studies, 
E2, but not P4, increased FGF7 mRNA (Ka et al. 2001).   
 The objective of the current study, was to investigate the extent to which E2 and 
P4 and their receptors contribute to FGF7 mRNA expression in the uterus of the pigs 
during later pregnancy, i.e., from Days 20 through 85.  We also assessed these same 
endpoints using short-term (Day 15) and long-term (Day 90) pseudopregnancy models.   
These experiments further support the role for steroid hormones and P4 in particular, as 
important regulators of FGF7 mRNA expression from Day 20 though 85 of pregnancy in 
the pig. 
 
Materials and Methods 
Animals and tissue collection 
 All experimental and surgical procedures complied with the Guide for Care and 
Use of Laboratory Animals and were approved by the Agricultural Animal Care and Use 
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Committee of Texas A&M University.  Sexually mature crossbred gilts were observed 
daily for estrous behavior. Gilts exhibiting at least two estrous cycles of normal duration 
(18–21 days) were assigned randomly to cyclic, pregnant or pseudopregnant status. Gilts 
for pregnancy were mated with crossbred boars. Gilts were hysterectomized on either 
Days 5 or 12 of the estrous cycle (Day 0 = estrus) or Days 9, 12, 13, 14, 15, 20, 25, 30, 
35, 40, 60, or 85 of pregnancy (n = 3 gilts per day). Pregnancy was confirmed by the 
presence of conceptuses of normal morphology in the uterine flushings on Days 9, 12, 13, 
14, and 15 or by visual observation of conceptus tissues undergoing attachment and 
placentation from Days 20 through 85.  
 Two different pseudopregnancy models were used to evaluate uterine estrogen 
receptor alpha (ESR1), and PGR protein expression and their role on FGF7 mRNA 
expression.  In both models, cycling gilts were randomly assigned on Day 0 
(estrus/mating) to pseudopregnant status (Bazer, 1992). For the model referred to as 
“short-term pseudopregnancy,” gilts received i.m. injections of estradiol benzoate (5 mg 
in 5 ml of corn oil/day) or corn oil alone (n =4/treatment) on Days 11, 12, 13, and 14 of 
the estrous cycle. Gilts were then ovariohysterectomized on Day 15.  For the second 
pseudopregnancy model referred to as “long-term pseudopregnancy,” gilts received i.m. 
injections of estradiol benzoate (5 mg in 5 ml of corn oil/day) on Days 11, 12, 13, 14 and 
15 of the estrous cycle and were subsequently ovariohysterectomized on Day 90 of 
pseudopregnancy. At hysterectomy, several sections (0.5 cm) from the middle portion of 
each uterine horn of both pregnant and pseudopregnant gilts were fixed in fresh 4% 
paraformaldehyde in PBS (pH 7.2) for 24 h and then embedded in Paraplast-Plus (Oxford 
Labware, St. Louis, MO).  
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In situ hybridization analysis 
 The location of FGF7 mRNA in uterine tissue sections was determined by in situ 
hybridization analysis as described previously (Ka et al. 2000).  Briefly, deparaffinized, 
rehydrated, and deproteinated uterine tissue sections (~ 5 m) were hybridized with 
radiolabeled antisense or sense porcine FGF7 cRNA probes that were generated from 
linearized plasmid templates using in vitro transcription with [35S]-UTP (Perkin Elmer 
Life Sciences, Inc). After hybridization, washes and digestion with RNase A, 
autoradiography was performed using Kodak NTB-2 liquid photographic emulsion 
(Eastman Kodak, Rochester, NY).  Slides were exposed at 4C for 2 wks, developed in 
Kodak D-19 developer, counterstained with Harris modified hematoxylin (Fisher 
Scientific, Fairlawn, NJ), dehydrated through a graded series of alcohol to Citrisolv 
(Decon Laboratories, Inc , King of Prussia, PA) and protected with cover slips.  
 
Immunohistochemistry 
 The expression of PGR and ESR1 antigens were evaluated in paraformaldehyde-
fixed, paraffin-embedded, uterine tissue cross-sections (4 m) using the procedures 
described previously (Spencer et al. 1995). Briefly a boiling citrate buffer antigen 
retrieval protocol was used to retrieve the PGR and Pronase E (0.5 mg/ml in PBS) was 
used to retrieve ESR1 antigen. The proteins were detected by using mouse anti-human 
PGR (2 g/ml; 2C5 PR, Zymed Labs, San Francisco, CA) and rat anti human- ESR1 (2 
g/ml; H222, Dr. Chris Nolan, Abbott Laboratories, Chicago, IL) and a Super ABC 
Mouse/Rat IgG Kit (Biomeda, Foster City, CA). For negative controls, primary 
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antibodies were substituted with mouse (for PR) or rat (for ER) IgG at the same 
concentration as the primary antibodies.  
 
Photomicrography 
 Digital photomicrographs of representative brightfield illumination 
(immunohistochemistry) or brightfield and darkfield illumination (in situ) images were 
evaluated with a Zeiss Axioplan2 microscope (Carl Zeiss, Thornwood, NY) fitted with an 
Axiocam HR digital camera.  Digital images of immunohistochemistry and in situ 
hybridization were recorded using Axiovision 4.3 software. All immunohistochemistry 
and in situ hybridization figures were assembled using Adobe Photoshop 8.0 (Adobe 
Systems Inc., San Jose, CA). 
 
Results 
ER expression in pig endometrium during pregnancy 
 Endometrial ESR1 expression was evaluated by immunohistochemistry during the 
interval from Day 20 through Day 85 of pregnancy in the pig.  In order to validate ESR1 
immunohistochemical results of ESR1 staining during later pregnancy, ESR1 staining 
was also performed on tissues| from Days 5 and 15 in cyclic pigs as well as Day 15 of 
pregnancy. Consistent with earlier findings (Geisert et al. 1993), ER expression was 
undetectable in the LE and stroma of Day 5 cyclic endometrium whereas ER was present 
in LE and stroma of Day 12 cyclic and Day 15 pregnancy (Figure 10).  From Day 20 to 
Day 85 of pig pregnancy, ESR1 was readily detectable in the LE and GE while stromal 
nuclear ESR1 staining remained high until Day 40 when it began to decline through Day 
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85 when relatively few immunostained stromal cells were detected. It is noteworthy that 
ER-positive cells were detected in the placenta in all days examined, Day 20 through 85. 
The nuclei of both trophoblast and allantois showed high levels of ESR1 (Figure 11).   
 
 
 
 
Figure 10. Immunohistochemical localization of nuclear ESR1 protein in paraffin-
embedded pig endometrium. Photomicrographs show the distribution of ESR1 in cyclic 
and early pregnant pigs. Nuclear immunostaining was detected in the luminal epithelium 
(LE), glandular epithelium (GE) and stroma (ST) of Day 12 cyclic and Day 15 pregnant 
pigs, whereas ESR1 protein was absent form endometrial compartments of Day 5 cyclic 
animals.  Sections from Day15 pregnant pigs incubated with nonimmune rat IgG (IgG) 
serve as negative controls. Width of each field 540 m.   
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Figure 11. Immunohistochemical localization of nuclear ESR1 protein in paraffin-
embedded pig endometrium. Photomicrographs show the effects of advancement of 
pregnancy on the presence and distribution of nuclear ESR1 protein in porcine 
endometrium and extraembryonic membranes. Nuclear ESR1 immunostaining was 
detected with variable intensity in the three endometrial cellular compartments, the 
luminal epithelium (LE), glandular epithelium (GE) and stroma (ST) while it is 
consistently present in the trophectoderm (TR) and other extraembryonic membranes 
during all days examined. Width of each field is 540 m. 
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PGR expression in pig endometrium during pregnancy 
 Immunohistochemical analysis of PGR was also examined in endometrium from 
Day 20 through Day 85 of pregnancy.  Validation of immunoreactive PGR was 
confirmed by PGR staining of endometrial tissue from Days 5 and 9 of the estrous cycle 
and Day 15 of pregnancy.  As reported previously by Geisert et al. 1994, PGR-positive 
nuclei in LE and GE were detected at highest levels on Day 5 and decreased to 
undetectable levels after Day 9 of the cycle and were also absent on Day 15 of 
pregnancy.  Further, PGR nuclear staining in stroma was present throughout the estrous 
cycle and early pregnancy (Figure 12).  The absence of PGR staining in LE and GE 
continued from Day 20 through Day 85 of pregnancy.  Stromal PGR was high on Day 20 
through Day 40 of pregnancy, however, as was seen with stromal ER, nuclear PGR 
staining declined after Day 40 and by Day 85, relatively few PR-positive stromal cells 
were detected (Figure 13). 
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Figure 12. Immunohistochemical localization of nuclear PGR protein in paraffin-
embedded pig endometrium. Photomicrographs show the distribution of PGR in the 
cyclic and early pregnant pigs. Nuclear immunostaining intensity was strong in the 
luminal epithelium (LE) and glandular epithelium (GE) of Day 5 cyclic pigs, whereas 
PGR protein was down-regulated  in the LE of Day 12 cyclic and Day 15 pregnant pigs.  
Sections from Day 15 pregnant pigs incubated with nonimmune mouse IgG (IgG) serve 
as negative controls. Width of each field 540m.   
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Figure 13. Immunohistochemical localization of nuclear PGR protein in paraffin-
embedded pig endometrium. Photomicrographs show the effects of advancement of 
pregnancy on the presence and distribution of nuclear PGR protein in porcine 
endometrium and extraembryonic membranes. There was no nuclear immunostaining in 
the luminal (LE) or glandular epithelia (GE) while the stroma (ST) showed strong 
immunoreactivity in the Days 20-35 pregnancy which decline later but did not disappear. 
The trophectoderm and other extraembryonic membranes did not show any PGR 
immunostaining. Width of each field is 540 m. 
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Figure 14.  In situ hybridization analysis of FGF7 mRNA expression in the porcine 
endometrium. The left and right panels represent corresponding brightfield and darkfield 
images, respectively, of endometrium for each treatment.  A representative section from 
Day15 pregnant pigs hybridized with a radiolabeled sense cRNA probe (Sense) serves as 
a negative control. FGF7 mRNA is detectable in LE of Days 12-85 of pregnancy. Note 
the the expression of FGF7 is gradually decrease to very low levels at the late stage of 
pregnancy. LE, lumenal epithelium; GE: glandular epithelium; ST: stroma; TR: 
trophectoderm.  Width of each field, 870 m.   
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FGF7 mRNA expression in pig endometrium during pregnancy 
 FGF7 mRNA expression was analyzed from Days 9 through Day 85 of 
pregnancy.  These data overlap and confirm previous data reported by Ka et al. (2000) in 
which FGF7 mRNA was undetectable on Day 9 of pregnancy but highly expressed in LE 
on Days 12 and 15.   In later pregnancy, FGF7 mRNA expression levels were high on 
Days 20 and 25, however, expression levels declined during later pregnancy and were 
very low by Day 85 (Figure 14).  
 
Analysis of ER, PGR and FGF7 mRNA during pseudopregnancy  
 Endometrial tissues from two different pseudopregnancy model systems were 
analyzed for ESR1 and PGR immunoreactivity and FGF7 mRNA expression and 
compared to a corn oil-treated control.  Strong immunoreactive ESR1 was detected in the 
LE of both the corn oil control and the long-term pseudopregnant animals (Day 90) 
whereas ESR1 staining in the LE of the short-term pseudopregnant animals (Day 15) was 
considerably lower (Figure 15).  PGR immunoreactivity was absent from the LE was and 
strong in the stroma in corn oil control, and both short-term and long-term 
pseudopregnant pigs (Fig 15).  FGF7 mRNA expression was relatively high in the LE of 
corn oil-treated and short-term pseudopregnant animals whereas FGF7 mRNA, was 
absent in the long-term pseudopregnant animals.  
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Figure 15.  Interrelationships between FGF7 mRNA, progesterone receptor protein and 
ESR1 protein in pseudopregnant pig endometrium.  First Column: Nuclear 
immunostaining for ESR1 protein was detected in luminal (LE), glandular (GE) epithelia 
(GE) and stromal cells (ST) of endometria from all treatment groups. Width of each field, 
540m.  Second Column: Nuclear immunostaining for PGR protein was detected in 
stroma cells (ST) of endometria from both treatment groups while PGR was undetectable 
in the LE.  Width of each field, 540 m.  Third and Fourth Columns: In situ hybridization 
analysis of FGF7 mRNA expression in pig endometrium. The left and right panels 
represent corresponding brightfield and darkfield images, respectively, of endometria 
from each treatment group.  Note that FGF7 mRNA is detectable only in LE and the 
hybridization signal is evident in endometrial of short-term pseudopregnant pig only.  
Width of each field, 690 m.   
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Discussion 
 The present study is an extension of results presented in the previous chapter in 
which the interplay between the actions of estrogen and P4 regulate FGF7 in the peri-
implantation uterus.  Reported here is an analysis of FGF7 mRNA expression in the 
uterus of pregnant pigs later in pregnancy (Days 20 through Day 85) in the context of 
ESR1 and PGR in endometrial LE and stroma.  The presence of FGF7 mRNA in the LE 
supports the hypothesis that FGF7 plays an important paracrine role in the developing 
conceptus as hypothesized in earlier studies by Ka et al. (2000, 2001).  
  The observation that FGF7 mRNA and protein were detected in the LE and 
uterine secretions respectively, and the presence of the FGF7 receptor, FGFR2IIIb 
mRNA in conceptus trophectoderm (Ka et al. 2000) is counter to a paradigm that 
described FGF7 as a mesenchymal factor released to act on the adjacent epithelium 
(Finch et al. 1989). Indeed, the hypothesis is that FGF7 in pig endometrial LE acts in an 
autocrine and/or paracrine manner to modulate the cellular activity of the trophectoderm 
and LE since FGFR2IIIb mRNA was also detected on the LE as well (Ka et al. 2000). 
Members of FGF growth factor family have been shown to affect cell growth, migration 
and protease synthesis directly and hence might be involved in tissue remodeling during 
pregnancy (Chai et al. 1998, Powers et al. 2000).  In the present study, the decline in 
FGF7 mRNA with the advancement of pregnancy is consistent with the reduced 
proliferative activity of trophectoderm cells as reported by Blankenship & King (1994), 
and this expression pattern supports a role of FGF7 in trophectoderm proliferation in vivo 
during the earlier stage of pregnancy. 
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 To study the effect of E2 and P4 on the expression of FGF7 mRNA, we examined 
ESR1 and PGR status in the pig endometrium since it is well established that both of 
these steroid hormones elicit their effects through ESR1 and PGR (Cooke et al. 1998a). 
As shown in Figs. 1 and 2, the expression of ESR1 varies with the physiological status as 
previously reported (Geisert et al. 1993).  ESR1 expression was undetectable in the LE 
and stroma of Day 5 cyclic animals while it was detected on Day 12 of the cycle and on 
Day 15 of pregnancy.  The current study further examined the expression of ESR1 and 
PGR from Day 20 to Day 85 of pregnancy. ESR1 was readily detectable in the LE and 
GE on all days examined while the population of stromal cells that were immunoreactive 
for ESR1 began to decline around Day 40 of pregnancy.  On the other hand, PGR 
expression was not detected in the LE from Day 20 through Day 85 and the stroma 
showed decreasing levels of PR-positive cells with the progression of the pregnancy. 
Previous studies showed increased FGF7 mRNA expression in the LE of the pig between 
Day 12 and 15 of the estrous cycle and pregnancy which peaked around Day 12 of 
pregnancy, the day which temporally coincides with the release of E2 from the conceptus 
for maternal recognition of pregnancy (Ka et al. 2000). In a later in vitro study, Ka et al. 
2001 reported that E2 increased FGF7 mRNA in a dose-dependent manner.  
 Results presented in the previous chapter indicate that, in ovariectomized pigs 
treated with steroid hormones, E2 increased FGF7 mRNA expression if, and only if, 
PGR is downregulated in the LE.  This is consistent with a similar report in sheep in 
which long-term exposure to P4 downregulated PGR in LE and while maintaining 
stromal PGR (Spencer et al. 2004b).  Therefore, we hypothesized that the increase in 
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FGF7 mRNA in animals treated with P4 alone was due to a putative progestamedin 
released from PR-positive stromal cells. 
 The current data from pregnant pigs examined from Days 20 through 85 showed a 
reduction  in the expression of FGF7 mRNA in LE which also coincides with reduction 
in PGR staining within stromal cells.  This reduction in FGF7 mRNA in LE might be 
related to reduction of soluble progestamedin levels released by PR-positive stromal cells 
which are in turn affected by P4 levels, the main regulator of secretory activity during 
this period (Roberts & Bazer 1988). Soluble factors appear to act as mediators of 
mesenchymal-epithelial interaction under other physiological conditions such as 
inflammation and tissue repair (Sporn & Roberts 1986). Fibroblast cells produce a 
number of soluble factors which function as paracrine regulators of neighboring epithelial 
cells (Stoker & Perryman 1985). The biological activity of these soluble factors and the 
nature of the ECM surrounding these cells are mutually interdependent parameters in the 
sense that many soluble factors such as TGF appear to exert a primary effect on the 
matrix biosynthesis by their responsive target cells (Ignotz & Massague 1986) and the 
response of the cells to soluble growth factors may be as well modulated by the nature of 
the ECM (Schor & Schor 1987). 
 However, the results from the two pseudopregnant pig models showed expression 
of FGF7 mRNA in LE at Day 15 (short-term pseudopregnant model) while FGF7 
mRNA was undetectable at Day 90 of the pseudopregnancy (long-term pseudo pregnant 
model).  In these animals the ESR1 was detected on the LE of both days 15 and 90 while 
PGR was only detectable at the stroma. The results from the short-term pseudopregnant 
study support our current studies that indicate exogenous or CL P4 could regulate FGF7 
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mRNA expression through the induction of progestamedins.  Although, the CL of 
pseudopregnant pigs appears to remain active as late as Day 110 of pseudopregnancy 
(Fuller W. Bazer, personal communication), the FGF7 mRNA was not detected at Day 
90 in the long term pseudopregnant model. The reason for this discrepancy remains to be 
determined.  It is possible, that conceptus factors may be required to maintain FGF7 
mRNA levels.  Endometrium from pregnant gilts secreted more protein, nondialyzable 
macromolecules, acid phosphatase activity, and retinol-binding protein than did 
endometrium from pseudopregnant pigs (Vallet et al. 1994, Vallet & Christenson 1996). 
Likewise, SPP1 is expressed by pig LE and high levels of SPP1 mRNA are elevated in 
LE in proximity to conceptus tissue whereas lower SPP1 mRNA expression was recorded 
in both short and long term pseudopregnant pigs (White et al. 2005).  There is a wide 
array of growth factors and cytokines, including interleukin-1, prostaglandin E, Type I 
and II interferons, and TFG-1, -2, and -3, all have been reported to be release by pig 
conceptus (Jaeger et al. 2001) which could influence FGF7 mRNA levels in LE. 
 An interesting finding in this study is the presence of ESR1 in placenta of the pig. 
Previous studies reported estrogen receptor expression in the placenta of human 
(Bukovsky et al. 2003a, b), rat (Al Bader 2006) and cattle (Schuler 2005). In the pig 
estrogen is synthesized and released by the conceptus in a three phases.  Between Days 
11 and 12, pig conceptuses produce estrogen which believed to be a critical component 
for the signaling mechanism for maternal recognition of pregnancy, followed by a second 
phase between Days 15 and 25 of pregnancy (Bazer et al. 1998). Later in pregnancy, 
there is another sustained high level of estrogen starting from Day 70 up to parturition 
(Knight 1994). In domestic animals, maternal and conceptus steroid hormones have 
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important interrelated roles in mediating different cellular activity during various stages 
of pregnancy (Jaeger et al. 2001). The current results of ESR1 expression in the 
trophectoderm are the first to suggest that conceptus derived estrogen could exert effects 
on the fetal and maternal tissues by interacting with these receptors in an autocrine and 
paracrine manner.  
 In conclusion, investigations on pig FGF7 regulation in the context of ESR1 and 
PGR expression during pregnancy and in pseudopregnant pigs clearly point to a role of 
steroid hormones and P4, in particular, as important regulators of FGF7 expression in 
throughout pregnancy in the pig. Expression of ESR1 in the placenta throughout 
pregnancy suggests that E2 may play important roles in the biology of pregnancy through 
out the gestation in the pig.  
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
SIBLING Proteins in the Uterus of Sheep 
 Immunocytochemical analysis of SIBLING proteins in the ovine uterus have 
uncovered evidence for the presence of DSPP, DMP1 and MEPE members of this protein 
family (but not BSP) in the uterus of sheep. Reagents were not available to search for a 
recently identified, more distantly related potential member of the SIBLING family, 
enamelin (ENAM) (Fisher & Fedarko 2003). The most striking finding of this study was 
the similarity in the expression pattern between DSPP and the previously reported 
expression of SPP1 in the sheep uterus (Johnson et al. 1999a, 2000, 2001. 2003b, 2006). 
While the multiple physiological roles of SPP1 within several tissue-level compartments 
of the uterus during pregnancy are in the early stages of being defined, there is growing 
evidence that SPP1 might be required for adhesion and signal transduction at the uterine-
placental interface and/or as a gene product expressed by uterine stroma as it decidualizes 
in response to conceptus invasion. DSPP is a chimeric glycoprotein with dentin 
sialoprotein (DSP) on its N-terminus and dentin phosphoprotein (DPP) on its C-terminus 
(Ritchie and Wang 1996); however, the LF-151 antibody used to localize DSPP was 
developed against a bacterial recombinant peptide recognizing the N-terminal “part of the 
DSP portion of human DSPP”.  It has not yet been determined whether staining 
recognized a “pro” form of DSPP or if the DSPP was proteolytically cleaved to DSP and 
DPP moieties (Ritchie & Wang 2000). Therefore, it is important to determine whether the 
expression of DSPP detected by immunocytochemistry in the stroma is secreted into the 
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matrix or is in an intracellular proDSPP form, or both.  Co-localization studies of the 
DSPP and a stromal-specific marker such as vimentin would help to address this issue.  
Alternatively, ultrastructural immunocytochemistry would be very useful if antigen 
preservation is adequate in tissues processed for electron microscopy.   
 In addition, further analysis the size of DSPP protein detected in uterine 
endometrium by Western blot analysis is warranted.  This would be useful to determine 
whether the immunoreactive protein represents full length DSPP or a proteolytically 
processed protein. It is noteworthy that SPP1 is proteolytically cleaved by MMPs into 
fragments with different biological activity (Agnihotri et al. 2001, Gao et al. 2004).   
Johnson et al., (1999b, 2003c) have identified full length SPP1 and SPP1 fragments using 
SPP1 antibodies (i.e., LF-124 and LF-123) which recognizes an N-terminal RGD 
containing increased biological activity for cell attachment and motility and a carboxy-
terminal fragment that identifies the full length protein and fragments with cell binding 
activity without promoting adhesion. Further analysis of the in situ processing of DSPP 
in the uterus is needed to determine if there is any type of functional redundancy between 
DSPP and SPP1. At the time of this investigation, however, antibodies were not available 
to analyze amino- and carboxy-terminal fragments of DSPP.  It is obvious that a more 
comprehensive analysis of spatial and temporal patterns of DSPP, DMP1 and MEPE 
mRNA and proteins throughout the estrous cycle and pregnancy is needed in order to 
begin to address the functional relevance of this protein family in uterine function.     
 All the SIBLING proteins display the RGD motif that mediates cell 
attachment/signaling via its reaction with cell surface integrins (Qin et al. 2004). All five 
v integrins, two 1 integrins (5 and 8) and IIb3 share the ability to recognize 
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ligands containing an RGD tripeptide active site (Humphries et al. 2006). Studies from 
sheep indicate the presence of v, 4, 5, 1, 3, and 5 integrin subunit mRNA and 
protein expression by endometrium of both cyclic and pregnant ewes (Johnson et a.l 
2001). Therefore, it is crucial to identify the specific integrin receptors capable of binding 
individual integrins.  An in vitro focal adhesion assay that has been previously used by 
Johnson et al. (2001) involving matrix coated polystyrene beads would be useful to 
identify integrin binding partners of individual siblings on cultured endometrial stroma 
and or luminal epithelial cells. 
 This investigation revealed that DMP1 and MEPE proteins were detected in the 
stroma of cyclic and pregnant animals. Earlier reports linked DMP1 expression to the 
high affinity binding and activation of MMP-9 (Fedarko et al. 2004) (also known as 
gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase).  The possible DMP1/MMP-
9 relationship was not investigated in this study but is a logical next step to evaluate the 
potential role of DMP1 in the ovine uterus.  While no specific MMP partner(s) for MEPE 
has been reported as yet, it is possible that a similar MMP relationship exists.  The co-
distribution of these two SIBLINGS suggests similarity in their biological roles in the 
uterus. An important future direction is an analysis of MMP distribution in the ovine 
uterus, and where indicated, colocalization analysis with appropriate SIBLING partners.  
As with DSPP, additional proteomic studies are needed to better characterize DMP1 and 
MEPE for further structural and functional studies. Moreover, using of the unilateral 
pregnancy model will be useful to evaluate the potential role of the conceptus on the 
expression of DMP1 and MEPE.  
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 Placentomal and interplacentomal endometrium are evident after day 40 of 
pregnancy in sheep (Boshier 1969). However, there are few reports regarding differences 
in gene expression within these compartment-specific regions of the uterus such as that 
reported for glycosylation dependent cell adhesion molecule 1-like protein (Muniz et al. 
2006). In the cow, which has cotyledonary type of placenta, the SPP1 expression showed 
compartmental differences (Pfarrer et al. 2002). Therefore, the compartmental variation 
in the SIBLING expression in the sheep should also be considered in any future studies.   
 
FGF7 Expression in Steroid Treated Pigs 
 The objective of this project was to test the hypothesis that FGF7 mRNA 
expression in endometrial LE of pigs is up-regulated by estrogen via ER present in 
endometrial epithelia and progesterone is also required as a permissive hormone to allow 
estrogen to stimulate FGF7 mRNA expression or to stimulate PGR positive stromal cells 
to release, a yet to be defined, progestamedin which in turn will upregulate FGF7 mRNA 
in LE.  We found that: 
 
1. In the absence of P4 and estrogen, the LE of CO-treated pigs expressed PGR which 
precluded expression of FGF7 mRNA (Fig. 16).  
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Figure 16. Porcine endometrium treated with corn oil. 
 
 
 
2. In P4-treated pigs, PGR were down-regulated in LE, but maintained in stromal cells, 
allowing production of a putative progestamedin-induction of FGF7 mRNA in LE (Fig. 
17). 
 
 
 
 
 
Figure 17. Porcine endometrium treated with P4 only. 
 
 
 
3. For pigs treated with P4 and ZK, uterine PGR are not functional in stromal cells which 
precludes progestamedin-induction of FGF7 mRNA in LE (Fig. 18).  
 
 
 
ESR1 PGR FGF7 
ESR1 PGR FGF7 
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Figure 18. Porcine endometrium treated with P4+ZK. 
 
 
 
4. Injection of estrogen alone did not induce FGF7 mRNA in LE because LE was PGR-
positive (Fig. 19).  
 
 
 
 
 
Figure 19. Porcine endometrium treated with estrogen alone. 
 
 
 
5. Treatment with P4 and estrogen allowed both down-regulation of PGR and induction 
of FGF7 mRNA in LE via either direct effects of estrogen on ESR1, effects of a 
progestamedin, or their combination (Fig.  20). 
 
 
ESR1 PGR FGF7 
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Figure 20. Endometrium of pig treated with estrogen and P4. 
 
 
 
6. LE of pigs treated with PZKE expressed FGF7 mRNA indicating estrogen
 
can directly 
induce FGF7 in the absence of functional PGR (Fig.  21). 
 
 
 
 
 
Figure 21. Endometrium of pig treated with estrogen, P4 and ZK. 
 
 
 
 Accordingly, we concluded that (Fig. 10) P4 is permissive to FGF7 expression by 
down-regulating PGR in LE. Moreover, P4 might stimulate PGR positive uterine stromal 
cells to release progestamedin that induces FGF7 expression by LE. Estrogen
 
and P4 can 
induce FGF7 in the absence of PGR rendered nonfunctional by ZK. Finally, estrogen
 
ESR1 PGR FGF7 
ESR1 PGR FGF7 
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from conceptuses interacts via ESR1 in LE to induce maximal expression of FGF7 on 
Day 12 of pregnancy in pigs.   
 An alternative hypothesis to the suggestion that a progestamedin is responsible for 
induction of FGF7 mRNA by LE has been offered by Geisert et al. (2005) in which these 
authors hypothesize that P4 interacts with PGR in LE to stimulate factors that activate 
nuclear factor kappa B (NF-B) which then functions to both inhibit PGR expression and 
activate transcription of genes believed to be involved with implantation (Geisert et al. 
2005).  Further investigations are required to explore these competing hypotheses.   An 
LE – stromal coculture approach might be useful to search for a potential stromal factor 
that might function as a progestamedin.  It might also be possible to utilize chemical 
(curcumin, PDTC, or salicylic acid) or biological inhibitors (NIK-KM or IKK-p DN) to 
NF-B DNA binding activity in porcine LE. 
 
ESR1, PGR and FGF7 Expression in Pregnant Pigs 
 The pattern of the expression of FGF7 as it has been recorded in the previous 
researches (KA et al. 2000, 2001, 2005, Chapter III) indicating a tight control of the 
estrogen and P4 on this gene either directly or indirectly. The current study is further 
suggesting the roles of these steroid hormones. It is also showed that the critical 
importance of FGF7 in the early stages of pregnancy in the pig is gradually decreases as 
the pregnancy progresses and in fact, this study advances our knowledge of how estrogen 
and P4 and their receptor work under normal physiological conditions. At this point, two 
key issues in P4 role need to be addressed; they relate to how P4 induces PGR positive 
stromal cells to release any hypothesized progestamedin and how these progestamedin 
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induces the production of FGF7. Another, area of investigation will be the role of 
estrogen in FGF7 regulation. Unfortunately, the long-term pseudopregnancy model was 
not consistent with the pregnancy data. Therefore, further investigation on the possibility 
of the conceptus factors is required. Moreover, further work will be required to fully 
understand the regulation of FGF7 expression in the pig during different phases of 
pregnancy and both pseudopregnancy models by evaluating the differences in the 
magnitude of the changes in circulating P4 and estrogen compared to the level of FGF7 
expression in the uterus.  
In this study we also reported the expression of ESR1 in the trophectoderm, 
mesenchymal cells and allantois of the pig in all pregnancy days examined. These results 
suggest a potential function of estrogen in fetal tissues. In domestic animals, maternal and 
conceptus steroid hormones have important interrelated roles in mediating different 
cellular activity during various stages of pregnancy (Jaeger et al. 2001). Therefore, 
further studies to determine the role of ESR1 in placental tissues will allow us to better 
understand the role of estrogen, which is synthesized and released by the conceptus at 
later stages of pregnancy (Knight 1994). 
 In these studies, we also verified the presence of FGF7 protein by Western blot 
analysis. Two immunoreactive bands were detected; one band was of the reported size of 
25 kDa while another immunoreactive band of 17 kDa was also detected. Preabsorption 
of the primary antibody with FGF7 before western analysis and neutralization of anti-
FGF7 with excess blocking peptide will be useful to establish the identity of this band.   
In conclusion, experiments in this dissertation have contributed toward the 
knowledge of how ESR1 and PGR expression in the LE and stroma could regulate gene 
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expression in the LE of the pig. Future experiments must be directed toward determining 
the cellular and molecular mechanisms by which the FGF7 might affect the LE and 
trophectoderm These experiments include:  (1) infusing FGF7 in the uterus of pig before 
the implantation and monitor the growth of the conceptus as well as for any 
differentiation in the conceptus tissues; (2) inactivating FGF7 in the LE and monitor the 
consequences on the development of the conceptus and pregnancy and (3) determining 
the genes affected by FGF7 treatment in endometrial explant cultures. 
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 APPENDIX A 
 
List of Antibodies Used to Detect SIBLING Proteins in Ovine Uterus: 
Gene Product Antiserum 
Name 
Antigen Source Known Species Comment References 
Human dentin 
sialophosphoprotein 
(DSSP) 
 
LF-151 
part of DSP portion of 
human DSPP, bacterial 
recombinant 
human and bovine, 
not mouse 
  
Human dentin 
matrix protein1 
(DMP1) 
 
 
LF-148 
CEHPSRKIFRKSRISE and 
CLKNIEIESRKLTVDAYH 
conjugated to KLH 
human and bovine, 
others not tested 
  
Human bone 
sialoprotein 
 
LF-83 
YESENGEPRGDNYRAYE 
 
D-[LPH] 
hum, man, dog epitope appears to 
be RAYED 
Bianco et al. 1993 
 
Mintz et al. 1993 
 
Human MEPE 
LF-155 last exon of human MEPE 
made in bacterial 
human, others not 
test                              
  
 
* Details regarding these and other rabbit polyclonal antisera derived against human antigen sequences can be found at the Matrix 
Biochemistry Laboratory website: http://csdb.nidcr.nih.gov/csdb/frame_mbu.htm 
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APPENDIX B 
 
 
 
 
 
Immunohistochemical localization of DSPP protein in ovine endometrium. 
Photomicrographs show the effects of reproductive status on the presence and intensity of 
DSPP protein in ovine endometrium. Stromal immunostaining intensity was strong on 
Days 45 through 120 of pregnancy while it was absent from the stroma of cyclic and 
early pregnant animals. The LE and GE immunostaining suggests that the protein may be 
secreted into the uterine lumen.  LE, luminal epithelia; ST: stroma; GE: glandular 
epithelia; PL: placenta. 
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